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ABSTRACT
Injectable hydrogels are important for use in tissue engineering due to their permeability
and biocompatibility. Those that have shear thinning properties allow for minimallyinvasive surgical procedures and a way to administer bioactive agents, and therapeutic
cells by injection. Currently available injectable hydrogels have a single or dual
input/stimulus for crosslinking which limits the range of mechanical properties and often
utilize potentially toxic ultraviolet radiation that reduces viability of injected cells. To
overcome these shortcomings, a tri-stimuli-responsive alginate-based injectable hydrogel
was developed based on: 1) supramolecular complex formation between β-cyclodextrin
(β-CD) conjugated alginate and thermo-responsive tri-block Pluronic® copolymers, 2)
visible light crosslinking via acrylate conjugation, and 3) ionic crosslinking of the
alginate backbone via exposure to calcium chloride.
The capabilities of the novel multi-stimuli injectable hydrogel were demonstrated with a
custom microfluidic devices (MFDs) to create microspheres encapsulating human
mesenchymal stem cell (MSCs). These experiments proved that the new hydrogel was
capable of serving as a stimuli responsive material for MSC cell delivery in the
therapeutic range of 10-1000 µm in diameter. In order to enhance the drug delivery
capabilities of the hydrogel, heparin sodium was conjugated onto the alginate backbone.
The affinity of the growth factor, vascular endothelial growth factor (VEGF), to the
heparin helped to prevent denaturing of the protein and improved vascularization. This
new tri-crosslinking hydrogel with conjugated heparin allows the end-user to control the
final physicomechanical and biochemical properties of the hydrogel using different
external stimuli. The tri-crosslinking hydrogel is a versatile material that has great
promise for a variety of soft tissue repair applications.
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conjugated alginate
Alg-MA-β-CD: Beta-cyclodextrin
conjugated methacrylated alginate
DI: Deionized water
LED: Light emitting diode
TEAO: Triethanolamine
PBS: Phosphate buffered saline

MWCO: Molecular weight cut off
MES: 2-morpholinoethanesulfonic acid
EDC: N-ethyl-N’(3dimethylaminopropyl) carbodiimide
hydrochloric acid
NHS: N-hydroxysuccinimide
TosCl: ρ-toluenesulfonyl chloride
EDA: Ethylenediamine
NaOH: Sodium hydroxide
HCl: Hydrogen chloride
Pa: Pascals
MSC: Mesenchymal stem cell
α-MEM: alpha-modified eagle medium
FBS: fetal bovine serum
EDTA: ethylenediaminetetraacetic acid
MFD: Microfluidic flow focusing
device
DOM: Degree of modification
Hep: Heparin
BMP: Bone morphogenetic protein
HGF: Hepatocyte growth factor
FGF-2: Fibroblast growth factor 2
bFGF: Basic fibroblast growth factor
PGF: Placenta growth factor
Alg-Hep: Heparin Conjugated Alginate
HUVEC: Human umbilical vein
endothelial cells

Latin Translations:
in situ: in position
in vivo: in a living organism
in vitro: outside a living organism (test tube/dish)
in ovo: in the egg
ex ovo: outside the egg
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CHAPTER 1: INTRODUCTION, BACKGROUND, AND SIGNIFICANCE
1.1. Medical Need
Medical advances in the past century have significantly increased the life
expectancy of a person in the United States from the late 40s in the early 1900s to the late
70s today (Xu et al., 2016). In order to continue improving medical care and extending
lifespans, new biomaterials are needed to support the growing field of regenerative
medicine. This field includes the delivery of cells and biomolecules to support tissue
regeneration and wound healing. Biomaterials are defined by the National Institute of
Biomedical Imaging and Bioengineering as “natural or synthetic [materials that] are used
in medical applications to support, enhance, or replace damaged tissue or a biological
function” (NIH, 2017). Biomaterials include, but are not limited to, ceramics, metals,
glass, and polymers. This research focused on the use of polymers as biomaterials;
specifically the subset of polymers known as hydrogels.
Hydrogels have numerous benefits in medical applications, including viscoelastic
material properties, biocompatibility, porosity, and biodegradability. For decades,
hydrogels have been used in regenerative medicine in a variety of applications.
Hydrogels deliver bioactive agents, serve as localized drug deposits, and encapsulate and
deliver cells. Hydrogels can also act as a scaffold system for tissue regeneration (des
Rieux et al., 2014). A scaffold supports cell migration and provides a location for the
deposition of an extracellular matrix, which is the first step in tissue regeneration. The
porous structure of a hydrogel allows for nutrient exchange, which supports cell viability,
new tissue growth, and integration with surrounding tissues (Lau et al., 2013). Currently,
hydrogels are used in the following tissue engineering applications.
•

Intervertebral disc degeneration (Pan et al., 2018)
1

•

Spinal cord regeneration (des Rieux et al., 2014)

•

Bone regeneration (Bai et al., 2017; Seo et al., 2017; Van et al., 2016)

•

Cell encapsulation/delivery (Haque et al., 2014)

•

Cardiovascular disease (Nie et al., 2009; Vong et al., 2018)

•

Wound healing (Sakiyama-Elbert et al., 2000)

•

Vascularization (Fujita et al., 2004; Nakamura et al., 2006)

•

Drug and chemotherapy delivery (Chang et al., 2011; Chen et al., 2018; Ning et
al., 2018).
Although there are several applications for current hydrogels, there are still

significant issues that can be addressed with the creation of a new formulation of a
hydrogel. Synthetic polymers are often bio-inert or have toxic fabrication or degradation
byproducts. Natural polymers are also used, due to being non-toxic, but have less
desirable mechanical properties than synthetic polymers. The chemical crosslinking
methods used in both synthetic and natural hydrogels are often toxic or involve the use of
ultra-violet (UV) light that can denature encapsulated proteins. Lastly, crosslinking must
sometimes be done prior to implantation in the body, resulting in an invasive surgical
approach to place the implant. The goal of this study was to address these concerns by
synthesizing a novel hydrogel that would overcome all of these shortcomings and could
be used for cell and drug delivery. The key advantageous characteristics that were
pursued included a natural biocompatible material, injectable and crosslinkable in situ
without the use of ultra-violet light, and mechanical properties that could be adjusted
depending on the medical application.
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1.2. Introduction to Hydrogels
A hydrogel is a polymer network that retains its three-dimensional shape and
remains insoluble in large amounts of an aqueous solution, such a biological fluid or
water (Payyappilly et al., 2014). Polymers that are in solution prior to crosslinking into a
hydrogel are called precursor solutions. Common examples of hydrogels include the
gelatin-based food Jell-O and contact lenses.
Hydrogels can be broken into two categories based on the source of materials used:
synthetic- or natural-based. Examples of synthetic-based hydrogels include poly(vinyl
alcohol) (PVA) or poly(ethylene oxide) (PEO). Synthetic hydrogels are advantageous,
due to inherent controllability and often stronger mechanical properties, but tend to be
less biocompatible than natural hydrogels (Drury et al., 2003). Examples of natural-based
hydrogels include gelatin, fibrin, keratin, collagen, and polysaccharides (chitosan,
alginate, and hyaluronic acid). The benefits of natural-based hydrogels are high
biocompatibility and biodegradability, but with the shortcoming of weak mechanical
properties (Saludas et al., 2017). This work focused on the use of natural-based
hydrogels, specifically sodium alginate.
Crosslinking techniques for hydrogels can also be divided into two categories:
physically crosslinked or chemically crosslinked. Physical crosslinking involves noncovalent bonds that are often reversible. These bonds can be formed through changes in
temperature, hydrogen bonding, hydrophobic interactions, or chain entanglement.
Chemical crosslinking often forms non-reversible covalent bonds. Bonds can be formed
from changes in pH, radiation, changes in ion concentration, and photopolymerization
with a light source, often UV.
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1.2.1. Sodium Alginate
Alginate (Alg) is a non-mammalian polysaccharide extracted from the cell wall of
brown seaweed. It is a renewable resource and a more sustainable option for polymer
stock production (Chee et al., 2011; Fertah et al., 2014; Hua et al., 2009; Rioux et al.,
2007). Due to the simple purification process required to extract alginate, the material
cost is low. Depending on seaweed location and processing technique, alginates can have
molecular weights of 10-1000 kDa (Baldwin et al., 2010). Alginate is non-toxic and
considered safe for human use; thus, it has been utilized since the 1940s in the cosmetic,
pharmaceutical, biomedical, textile and food industries (Chou et al., 2009; Fertah et al.,
2014).
Alginate’s solubility and gelation kinetics are dependent on the specific ions in
solution, the pH, and the polymer molecular weight and concentration (Sabra et al.,
2001). Traditionally, alginate is crosslinked to form a hydrogel in the presence of divalent
cations, reacting with adjacent carboxylic acid moieties (Kühbeck et al., 2015; Miao et
al., 2014; Rhim, 2004). The structure of alginate is similar to a major component of the
extracellular matrix, glycosaminoglycan (Tanihara et al., 2001). The structure of sodium
alginate can be seen in Figure 1.

Sodium Alginate
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Figure 1: Chemical structure of sodium alginate

Alginate contains a large number of available carboxyl and hydroxyl groups in its repeat
unit, which provide active sites for chemical functionalization. This will alter chemical
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properties, and control the network formation and mechanical behavior of alginate
hydrogels (J.-S. Yang et al., 2011).
1.3. Rheology
Rheology was defined as “the science of deformation and flow” by Professor
Bingham in the late 1920s (Barnes et al., 1989; Rao, 2010; Sunthar, 2010). The
origination of rheology comes from the Greek “rhei” which means “to flow” (Janmey et
al., 2008; Mezger, 2015). It can be used to determine specific material properties, such as
viscosity and gelation kinetics. The basic principles of rheology involve the force applied
to a material (stress), the deformation of the material (strain), and the relationship
between the strain and stress, which can be used to calculate viscosity and other
mechanical properties (Janmey & Schliwa, 2008).
Shear stress (t) is equivalent to the shear force (F) divided by the shear area (A), as
seen in Equation 1. Shear stress is measured in newtons (N) divided by meters squared
(m2) or pascals (Pa).
𝜏=

𝐹
𝐴

Equation 1

Area=A

F

Figure 2: Shear stress diagram

Shear rate (𝛾̇ ) is equivalent to the velocity (v) divided by the shear gap (h), as defined in
Equation 2. The units for shear rate are reciprocal seconds (1/s or s-1).
𝛾̇ =

𝑣
ℎ

Equation 2
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s

h
Figure 3: Shear rate diagram

Shear strain (g) is equivalent to the deflection path(s) divided by the shear gap height (h)
as defined in Equation 3. Shear strain is unitless.
g=

𝑠
ℎ

Equation 3

Area=A

v

h
Figure 4: Shear strain diagram

In order to measure the rheological properties of a material, a machine called a rheometer
can be used.
1.3.1. Rheometer
+,

A rotation rheometer measures or controls three variables: angular velocity [ +- =
Ω(𝑡)], angular displacement [𝜃(𝑡)], and torque [𝑀(𝑡)]. With these measured values, the
stress [𝜏(𝑡)], strain [𝛾(𝑡)], strain rate [𝛾̇ (𝑡)], viscosity [𝜂(𝑡)], and modulus [𝐺(𝑡)] in
relation to time can all be measured using the following equations. The constants 𝐾7
and 𝐾9 are specific values based on the geometry of the rheometer (TA-Instruments).
𝜏(𝑡) = 𝐾7 𝑀

Equation 4

𝛾(𝑡) = 𝐾9 𝜃

Equation 5
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𝛾̇ (𝑡) = 𝐾9

𝑑𝜃
= 𝐾9 Ω(𝑡)
𝑑𝑡

Equation 6

𝜂(𝑡) =

𝜏(𝑡)
𝛾̇ ;

Equation 7

𝐺(𝑡) =

𝜏(𝑡)
𝛾;

Equation 8

1.3.1.1. Cone and Plate Geometry
A cone and plate geometry is used for materials with viscosity ranging from very
low to very high. Cone and plate was used in this study’s experiments in order to fully
characterize the material. A diagram of the cone and plate geometry of a rheometer can
be seen below, where ‘r’ is the radius and ‘a’ is the angle of the cone. A rheometer can
calculate the viscosity of a material using the measured torque (M) and the angular
velocity of the cone (𝜔), as seen in Equation 9 (McGregor, 2009).
𝜂=

3𝛼𝑀
2𝜋𝑟 B 𝜔

Equation 9

Ω, T
r

$

Sample
Peltier Plate

Figure 5: Cone and plate geometry
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1.3.2. Viscosity
Viscosity is defined as “a measure of the resistance of fluid to an applied stress”
(Scientific, June 18 2018). It is most often thought of as describing the internal friction of
a material caused by the molecules and/or particles within a solution. The higher the
viscosity, the “thicker” the solution (e.g. maple syrup), the lower the viscosity, the
“thinner” the solution (e.g. water).
Viscosity (h) is equivalent to the shear stress (t) divided by the shear rate (𝛾̇ ), as
defined in Equation 10; it is measured in pascals per second (Pa/s). The viscosity
equation is derived from Newton’s Law of Viscosity, which states “the shear stress
between adjacent fluid layers is proportional to the negative value of the velocity gradient
between the two layers” (Varzakas et al., 2014).
h=

t
𝛾̇

Equation 10

By combining Equation 4, Equation 5, Equation 7, and Equation 10, the result is the
equation for the viscosity for a rotational rheometer, as below.
h=

t
𝑀 ∗ 𝐾D
=
𝛾̇ Ω(𝑡) ∗ 𝐾9

Equation 11

For Newtonian fluids, such as water, viscosity is independent of the shear rate. Polymer
precursor solutions are non-Newtonian fluids, such that the viscosity is dependent on the
applied shear rate.
A shear thinning material, also referred to as a pseudoplastic material, presents
with a decreasing viscosity as the shear rate is increased. This is caused by the materials
within the fluid aligning with the direction of the flow. For a shear thickening material, or
a dilatant material, viscosity increases as shear rate increases (Björn et al., 2012). An
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example of a shear thinning material is ketchup and an example of a shear thickening
material is corn starch in water.

Figure 6: Materials showing Newtonian behaviors, shear thickening (dilatant properties), or shear
thinning (pseudoplastic properties) as the shear strain rate is increased.

For this project, it is important that the polymer precursor solutions have shear thinning
or Newtonian fluid behaviors when exposed to shear forces in order to facilitate an easy
injection process into the body.
1.3.2.1. Curve Fitting
To determine whether a material is shear thinning, the viscosity values can be used
in conjunction with curve fitting equations (Syntouka et al., 2018). The Ostwald model,
also called the Power Law model, identifies shear thinning materials. The Power Law can
be seen in Equation 12, where h is the viscosity, 𝛾̇ is the shear rate, m is the slope, and n
is the flow behavior index. When the flow behavior index n=1, the fluid has Newtonian
behavior. When n<1, the material has pseudoplastic (shear-thinning) behavior, and when
n>1, the material has dilatant (shear-thickening) behavior. This model does not accurately
describe the Newtonian plateau that can occur in shear thinning materials at low shear
rates (Björn et al., 2012).
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h = 𝑚 ∗ 𝛾̇ FGH

Equation 12

The Carreau-Yasuda model is a curve fitting model with higher accuracy than the
Power Law model, due to an increased number of parameters. The Carreau-Yasuda
Model can be seen in Equation 13, where h is the viscosity, 𝛾̇ is the shear rate, hI and h;
relate to plateau viscosities, 𝜆 is a time constant, and 𝛼 relates to the transition area shape.
This curve fitting model allows for better prediction of how a material will behave under
various shear stresses (Andrade et al., 2007).
h = hI + Lh; − hI N[1 + (𝜆𝛾̇ )Q ] (FGH)/Q

Equation 13

The Carreau-Yasuda Model can also be used to predict the viscosity values that may be
outside of the measurement range of a rheometer.
1.3.3. Viscoelastic Materials
Viscoelastic materials display the behaviors of both a solid (elastic properties) and
a liquid (viscous properties). The relationship between stress and strain is also dependent
on time. Shear modulus (G) is equivalent to the shear stress (t) divided by the shear strain
(g), as seen in Equation 14. Shear modulus is measured in pascals (Pa) (Sunthar, 2010).
𝐺=

t
g

Equation 14

By combining Equation 14 with the rheometer geometry equations, the equation for shear
modulus using a rotational rheometer is described below.
t 𝑀 ∗ 𝐾D
𝐺= =
g 𝜃 ∗ 𝐾9

Equation 15

Phase shift (d) is the offset angle or lag between the shear strain and the resulting
shear stress of a material. The phase shift is measured in degrees (°). In a purely elastic
material d=0° and for a purely viscous material d=90°. A viscoelastic material with a
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phase shift between 45° and 90° is considered to be in a fluid-like state, and a material
with a phase shift between 0° and 45° is considered to be in a gel-like state.
The storage or elastic modulus is represented by the variable G’. The storage
modulus relates directly to the ratio of the in-phase (or elastic) stress to the strain of the
material. This value represents the elastic component of the material. The loss modulus of
a material is represented by the variable G’’. The loss modulus describes the ratio of the
out-of-phase (or viscous) component to the stress. This value characterizes the viscous
component of the material (Lakes et al., 2009). The tangent of the phase shift (d) can be
found by dividing the loss modulus (G’’) by the storage modulus (G’), as seen in
Equation 16 (Mezger, 2015).
𝑡𝑎𝑛 𝛿 =

𝐺 WW
𝐺′

Equation 16

When G’ (storage modulus) is higher than G’’ (loss modulus), the material is considered
to be more elastic. For hydrogels, crosslinking occurs when G’ surpasses G’’, indicating
that the material properties have shifted from mainly viscous to mainly elastic (Franck et
al.) (Mezger, 2015). This crossover data represents the gelation kinetics of the hydrogel,
which consist of the time, temperature, etc. of the polymer precursor solution when it
becomes a crosslinked hydrogel.
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Figure 7: Hydrogel crosslinking when the storage modulus (G’) is higher than the loss modulus (G’’)
indicating the material properties are more elastic than viscous.

1.4. Drug Delivery
The highly porous structure of hydrogels is ideal for drug delivery. Pharmaceutical
drugs, including growth factors and proteins, can easily be loaded into the polymer
precursor and crosslinked. For example, using a hydrogel as a drug delivery vehicle for
chemotherapeutics allows for a dose to be delivered directly into or adjacent to the tumor,
which can reduce the toxic effects on the whole body (Chen et al., 2018). In addition,
encapsulation in a hydrogel can deliver a high enough concentration of a
chemotherapeutic to be pharmacologically beneficial. Due to direct injection into the
tumor, there is an increase in efficacy of the chemotherapeutic drug, as it has a shorter
distance to travel (Ning et al., 2018). The encapsulation of drugs within the hydrogel
provides tunable release kinetics. In the following studies, the release of a growth factor
was examined using multi-crosslinking hydrogels.
One of the current goals of tissue engineering is to create a biomaterial that
promotes the localized angiogenic response to form new blood vessels (Andrea Zieris et
al., 2010). Angiogenesis is the formation of new blood vessels from pre-existing vessels.
Angiogenesis is only found during embryonic development with the two exceptions
12

being the reproductive systems of females and the wound healing process (A Zieris et al.,
2011). Without proper vascularization, cells embedded into the scaffold will die from
lack of oxygen (hypoxia) or lack of nutrients. In order for a biomaterial to induce
angiogenesis, it should have mechanical properties similar to the surrounding tissues, as
well as the ability to stabilize growth factors for local delivery (Andrea Zieris et al.,
2010). A previous study showed that encapsulating vascular endothelial growth factor
(VEGF) in alginate increased vascularization density in comparison to alginate without
VEGF (Hao et al., 2007). The drug delivery chapter focuses on the encapsulation and
delivery of VEGF from modified hydrogels.
1.5. Statistical Analysis
In order to assess if any of the chemical modifications to the alginate backbone or
the different crosslinking methods caused a significant change in the behavior of the
hydrogel, statistical analysis was performed. When comparisons were made between only
two groups, a T-test was used. A two sample T-Test assuming unequal variances was
employed with an a=0.05 for a 95% confidence level. T-Tests resulting in p values of
less than or equal 0.05 were considered to be significant results. T-Tests were performed
using the Analysis ToolPak in Excel.
When more than two groups are compared, a T-Test is no longer an acceptable
statistical method. When individual T-Tests are run, i.e. comparing four groups, such as
group 1 to 2, and group 1 to 3, and so on, the a value of 0.05 for 95% confidence is
compounded. When six T-Tests are run to individually compare the four different groups,
the confidence goes from 95% to 73.5%. In order to test multiple groups, an analysis of
variance (ANOVA) is required. The results of an ANOVA are broken down into two
parts (variation within the group and variation between groups). When the variance
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between the groups is large and the variance within the groups is low, the null hypothesis
is rejected and there is at least one mean that is an outlier. When the variance between the
groups and the variance within the groups is similar, the null hypothesis is not rejected,
and all means of the groups are similar. When the variance between groups is small but
the variance within the groups is large, the null hypothesis is rejected, and the means of
the groups are similar. If the results of the ANOVA suggested a significant difference
between the groups, a Bonferroni multiple comparison post-hoc test could be used to
determine which groups were significantly different from each other. ANOVA and
Bonferroni results with p values of less than or equal to 0.05 were considered to be
significant results in this study and were performed using GraphPad software
(Bronckaers et al., 2013; McHugh, 2011).
1.6. Significance
Biomimicry is one of the crucial components of tissue engineering. Ideally, an
engineered scaffold should mimic the mechanical properties of the surrounding native
tissue. Currently, the mismatch of hydrogel mechanical properties to native tissues are
part of the reason why the injectable materials do not allow for the full repair or
replacement of diseased or damaged tissues (Q. Wang et al., 2016). In order to control the
mechanical properties of the hydrogel, the alginate backbone was modified to allow for
three different crosslinking techniques that result in various mechanical properties. A key
aspect of the chemical modifications was that it allowed for the hydrogel to be
crosslinked using different temperatures, ion concentrations, or photopolymerization with
visible green light (510 nm). This is beneficial over other types of crosslinking, such as
those that require UV light. The hydrogel can then be imbedded with stem cells, patient
specific cells, or other drugs / growth factors without the harsh UV light causing cell
14

death or denaturing proteins (C. Bahney et al., 2011). Previous studies have shown
that protecting stem cells within a hydrogel during injection increases cell viability
compared with suspension in phosphate buffer solution (PBS) (Cai et al., 2015).
A scaffold system should mimic the biochemical properties as well as the
biophysical of the extracellular matrix (Lau & Wang, 2013). Biofunctional additives can
be integrated into a hydrogel through chemical grafting onto a polymer backbone or
physically blending materials into the hydrogel precursor solutions (Lau & Wang, 2013).
A crucial component for creating 3D scaffold systems in soft tissue engineering is the
promotion of vascularization within the hydrogel network. The addition of conjugated
heparin and heparin-binding growth factor VEGF can control the release of VEGF into
the hydrogel system and surrounding tissue in order to induce the formation of blood
vessels. The chemical modifications to the natural-based hydrogel alginate allowed for
the fabrication of a hydrogel system that can be mechanically and biologically tuned for
use in a variety of tissue engineering applications including cell delivery and controlled
drug delivery for in situ tissue regeneration.

15

2.

CHAPTER 2: TRI-STIMULI RESPONSIVE POLYMER SYNTHESIS
2.1. Introduction
Although sodium alginate can be crosslinked with divalent cations, such as calcium

chloride, the structure is considered to be unstable, due to the exchange of monovalent
cations for divalent cations. The exchange can cause large variation in degradation
profiles and mechanical properties (Baldwin & Kiick, 2010). To increase mechanical
stability and tunability, alginate was chemically modified to crosslink with a photoinitiator system. One such derivative of alginate is methacrylated alginate (Alg-MA),
synthesized via esterification of the hydroxyl groups with methacrylic anhydride (Chou et
al., 2009; Smeds et al., 2001; Wagner et al., 2014). The acrylate functional group formed
covalent crosslinks between alginate chains by free radical polymerization in the
presence of a photo-initiator and exposure to light (Lee et al., 2012; Möller et al., 2011;
Xuanhe Zhao et al., 2010). Using this unique approach, the efficacy of visible light
exposure, rather than ultraviolet (UV) light exposure, to covalently crosslink alginate was

Methacrylic
Anhydride
investigated (Charron et al., 2016;
Fenn & Oldinski,
2016).
O

O

O

Figure 8: Chemical structure of methacrylic anhydride

In addition to covalent and ionic crosslinking, alginate was chemically modified to
form reversible, supramolecular hydrogel networks based on guest-host physical
interactions (Rodell et al., 2016). Cyclodextrins are cyclic oligosaccharides, comprised of
six, seven or eight D-glucopyranose units, which correspond to the classification of the
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specific type of cyclodextrins; i.e., α-, β-, and γ-, ordered by α-1,4-glucosidic bonds
(Bibby et al., 2003; Moses et al., 2000; Zhang et al., 2010).
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Figure 9: Chemical structure of β-cyclodextrin

The unique bond formation of cyclodextrins creates cup-like cavities, with hydrophobic
interior surfaces and hydrophilic exterior surfaces (Rojas et al., 1995; X. Wang et al.,
1993).

Hydrophilic Exterior

Hydrophobic Interior

Figure 10: 3D “cup-like” shape of cyclodextrin with hydrophilic exterior and hydrophobic interior

Cyclodextrins were covalently grafted onto polysaccharide chains via carbodiimide
chemistry, and thus were used to form reversible, physical bonds with various molecules
and/or polymers (J.-S. Yang et al., 2011). The hydrophobic nature of the interior of these
molecules allowed for the inclusion of many different types of hydrophobic or
amphiphilic guest molecules / polymers and created physical crosslinks via non-covalent
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interactions (Bibby & Mercier, 2003; Catena et al., 1989). Various guest polymers may
be utilized, including Pluronics®, which are thermo-responsive, tri-block copolymers,
consisting of two hydrophilic end blocks with a hydrophobic middle block.

Pluronic
F108

Guest-Host Interactions

PEG-b-PPG-b-PEG
Figure 11: Pluronic F108 [Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene
glycol)] guest-host interactions between the hydrophobic PPG block and the interior of the
cyclodextrin cavity

The hydrophobic inner blocks of two specific Pluronic® molecules, F-108 and F127, were small enough to enter the interior cavities of β-cyclodextrin (β-CD) groups.
The addition of a Pluronic® copolymer introduced a temperature-dependent crosslinking
method for the β-CD modified alginate materials, adding another dimension of control
over the hydrogel’s mechanical properties (Miao et al., 2015; Sala et al., 2017). These
chemical modifications allowed for a single polymer chain to be crosslinked using three
independent methods: temperature increase, exposure to visible green light, and exposure
to calcium chloride.
2.2. Materials
Sodium alginate (PROTANAL® LF200 FTS, Mv = 67−142 kg/mol) was kindly
donated by FMC Biopolymer. Methacrylic anhydride, calcium chloride (CaCl2), N-ethylN’(3-dimethylaminopropyl) carbodiimide hydrochloric acid (EDC), Nhydroxysuccinimide (NHS), Pluronic® F-127 [poly(ethylene oxide)-blockpoly(propylene oxide)-block-poly(ethylene oxide), PEO-b-PPG-b-PEO, Mn = 13
kg/mol], Pluronic F108 [Poly(ethylene glycol)-block-poly(propylene glycol)-blockpoly(ethylene glycol)], triethanolamine, eosin Y, and 1-vinyl-2-pyrrolidinone were was
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purchased from Sigma Aldrich. β-cyclodextrin (β-CD), ρ-toluenesulfonyl chloride
(TosCl), acetonitrile, acetone, and ethylenediamine (EDA) were purchased from Acros
Organics. Sodium hydroxide (NaOH), hydrogen chloride (HCl), phosphate buffered
saline (PBS), and the 2-morpholinoethanesulfonic acid (MES) buffer were purchased
from Thermo Fisher Scientific.
2.3. Chemical Modifications
The conjugation process of creating a single modified polymer based on an alginate
backbone is depicted below. The first step was to add the acrylate group onto the alginate
backbone followed by the conjugation of β-cyclodextrin. Carbodiimide crosslinking
chemistry (EDC/NHS coupling) was first used to attach an amine function group to βcyclodextrin to form β-CD-EDA, followed by a second round of carbodiimide
crosslinking chemistry to attach the β-cyclodextrin onto the alginate backbone.
2.3.1. Methacrylated Alginate (Alg-MA)
To modify the degree of modification of the acrylate group between 1-4%, sodium
alginate was dissolved in PBS to create a 1% (w/v) solution at room temperature. A 10fold molar excess of methacrylic anhydride was added to the alginate solution. The pH of
the solution was periodically adjusted to 8.5, using 5 N NaOH. The methacrylation
reaction was conducted for 24 hours. The final pH was adjusted to 7 using 5 N NaOH.
The methacrylated alginate (Alg-MA) solution was purified via dialysis (molecular
weight cut off (MWCO) = 6-8 kDa) against deionized water for three to five days and
lyophilized to yield a dry product.
To modify the degree of modification of the acrylate group between 4-8%, sodium
alginate was dissolved in PBS to create a 1% (w/v) solution at room temperature. A 10fold molar excess of methacrylic anhydride was added to the alginate solution. The pH of
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the solution was periodically adjusted to 10, using 5 N NaOH. The methacrylation
reaction was conducted for 24 hours, after which another 10-fold molar excess of
methacrylic anhydride was added to the alginate solution. The pH of the solution was
periodically adjusted to 10, using 5 N NaOH. The methacrylation reaction was conducted
for an additional 24 hours. The final pH was adjusted to 7 using 5 N NaOH. The
methacrylated alginate (Alg-MA) solution was purified via dialysis (MWCO = 6-8 kDa)
against deionized water for three to five days, and lyophilized to yield a dry product.
Alg-MA
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Figure 12: Chemical synthesis of Alg-MA

2.3.2. β-Cyclodextrin Conjugation (Alg-β-CD & Alg-MA-β-CD)
For β-cyclodextrin conjugated to sodium alginate, Alg (3.0 g) was dissolved in 0.1 M
MES buffer (pH 5.6, 150 mL) to which carbodiimide hydrochloric acid (EDC) (2 g) and
N-hydroxysuccinimide (NHS) (1.2 g) were added. After mixing for 30 minutes at room
temperature, β-CD-EDA (4.5 g) was added under vigorous mixing at room temperature for
one day. The Alg-β-CD solution was purified via dialysis (MWCO = 6-8 kDa) against
deionized water for three to five days, and lyophilized to yield a dry product.
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Figure 13: Chemical synthesis of Alg-β-CD
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For β-cyclodextrin conjugated to methacrylated sodium alginate, Alg-MA (3.0 g) was
dissolved in 0.1 M MES buffer (pH 5.6, 150 mL) to which EDC (2 g) and NHS (1.2 g)
were added. After mixing for 30 minutes at room temperature, β-CD-EDA (4.5 g) was
added under vigorous mixing at room temperature for one day. The Alg-MA-β-CD solution
was purified via dialysis (MWCO = 6-8 kDa) against deionized water for three to five days,
and lyophilized to yield a dry product.
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2.4. Nuclear Magnetic Resonance (NMR)
To verify functional group conjugations onto the alginate backbone, dried polymer
products were each dissolved in D2O (1% w/v). 1H-NMR was performed on a Bruker
AVANCE III 500 MHz high-field NMR spectrometer, for 16-32 scans at 20 Hz.
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Figure 15: NMR spectra for sodium alginate
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Figure 17: Left: Schematic representing the chemical modification to non-modified sodium alginate
(Alg, top), methacrylated alginate (Alg-MA, middle), and methacrylated alginate conjugated with βcyclodextrin (Alg-MA-β-CD, bottom). Right: 1H-NMR spectral analysis of Alg (top), Alg-MA
(middle), and Alg-MA-β-CD (bottom) solutions in D2O at room temperature. Peaks identified as ‘a’
and ‘b’ demonstrate methacrylation of the alginate, and the peak identified as ‘c’ demonstrates b-CD
conjugation onto Alg-MA.

2.5. Conclusion
NMR spectral analysis confirmed the successful methacrylation of sodium alginate,
as well as the conjugation of β-CD onto alginate and Alg-MA using aqueous-based
chemistry. The acrylate groups on Alg-MA and Alg-MA-β-CD were identified as peaks
at 6.1 ppm and 5.7 ppm, as well as 1.9 ppm. The addition of β-CD was identified by the
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peak at 1 ppm; see Figure 17. The above chemistry resulted in a tri-stimuli-responsive
alginate-based hydrogel that can be crosslinked via:
1) supramolecular complex formation between β-cyclodextrin (β-CD)
conjugated alginate and thermo-responsive tri-block Pluronic® copolymers,
2) visible light crosslinking through acrylate conjugation, and/or
3) ionic crosslinking of the alginate backbone through exposure to calcium
chloride.
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3.

CHAPTER 3: TRI-STIMULI RESPONSIVE HYDROGEL MECHANICAL
TESTING
3.1. Introduction
Injectable hydrogels are ideal for regenerative medicine. These hydrogels allow for

materials to fill oddly shaped defects entirely and reduce the pain or discomfort of the
patient, as a minimally invasive application technique (Bai et al., 2017; Ning et al., 2018;
Pan et al., 2018). The low stiffness of injectable hydrogels, compared with solid implants,
minimizes damage to the tissue surrounding the injection site (Elias et al., 2015). The less
invasive surgeries also reduce surgical time and scar size (des Rieux et al., 2014;
Payyappilly et al., 2014). Injectable hydrogels allow for the successful delivery of
sensitive molecules, for example proteins, that could denature or degrade if administered
orally or via a transdermal injection (Payyappilly et al., 2014). Specifically, hydrogels
that can be crosslinked in-situ are ideal, because a matrix is formed for drug and/or cell
delivery (Van et al., 2016). In order to retain the encapsulated cells or drugs, it is
important that the in-situ method of crosslinking is mild (Gregoritza et al., 2016). The tristimuli responsive hydrogel synthesized in the previous chapter is ideal as an injectable
hydrogel, because alginate is instinctively shear thinning and the chemical modifications
allow for mild crosslinking in situ.
An AR2000 stress-controlled rheometer (TA Instruments) was used for the
following gelation experiments and the physico-mechanical characterization of alginatebased polymer solutions and hydrogels. The tests performed to determine the viscosity of
the polymer precursors were shear-rate controlled. The shear-rate controlled tests
determined how the material would flow through a tube, such as a syringe/needle during
the injection process (Mezger, 2015). The gelation kinetics were also studied in order to
24

characterize the effects of varying photo-initiator concentrations, polymer concentrations,
and tri-block Pluronics®. The results from the gelation kinetic testing determined the
speed at which the hydrogel crosslinked and the mechanical strength of the hydrogel.
3.2. Materials
Sodium alginate (PROTANAL® LF200 FTS, Mv = 67−142 kg/mol) was kindly
donated by FMC Biopolymer. Methacrylic anhydride, Calcium Chloride (CaCl2), Nethyl-N’(3-dimethylaminopropyl) carbodiimide hydrochloric acid (EDC), Nhydroxysuccinimide (NHS), Pluronic® F-108 [poly(ethylene glycol)-blockpoly(propylene glycol)-block- poly(ethylene glycol) (PEG-b-PPG-b-PEG), Mn = 15
kg/mol], Pluronic® F-127 [poly(ethylene oxide)-block- poly(propylene oxide)-blockpoly(ethylene oxide) (PEO-b-PPG-b-PEO), Mn = 13 kg/mol], triethanolamine, eosin Y,
and 1-vinyl-2-pyrrolidinone were purchased from Sigma Aldrich. β-cyclodextrin (β-CD),
ρ-toluenesulfonyl chloride (TosCl), acetonitrile, acetone, and ethylenediamine (EDA)
were purchased from Acros Organics. Sodium hydroxide (NaOH), hydrogen chloride
(HCl), phosphate buffered saline (PBS), and the 2- morpholinoethanesulfonic acid (MES)
buffer were purchased from Thermo Fisher Scientific.
3.3. Rheological Characterization and Gelation Kinetics
A 20 mm diameter 1°59’6’’steel cone geometry with a gap height of 57 µm was
used. Photo-initiator stock solutions were prepared with 0.5% eosin Y (photosensitizer,
EY) in 1-vinyl-2-pyrrolidinone (catalyst, 1VP) and 5 M triethanolamine (initiator,
TEOA) in deionized (DI) water. Control and experimental polymer solutions were
prepared in PBS with photo-initiators added to the following final concentrations: 0.5%
(v/v) eosin Y stock solution and 5.0% (v/v) TEOA stock solution (Nettles et al., 2004;
Park et al., 2003; Smeds & Grinstaff, 2001). Polymer solutions were equilibrated in
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complete darkness at room temperature for at least 24 hours before testing. For each test
described below, three or more experimental trials were performed, and averages were
reported, unless otherwise stated.
3.4. Effect of Chemical Modification on Polymer Precursor Solutions
Oscillatory experiments were performed on each test group at room temperature to
ensure that the chemical modifications to alginate did not result in undesired mechanical
properties, such as instability. For time sweep experiments, a 1% radial strain was applied
at a frequency of 10 Hz. Strain sweeps were performed at 10 Hz, and frequency sweeps
were performed at 0.5% radial strain.
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Figure 18: Rheological data for alginate controls (Alg), and chemically modified alginate (Alg-MA,
Alg-β-CD, Alg-MA-β-CD), measured at 25°C to characterize the effects of chemical modification on
polymer precursor solutions: A) Oscillatory time sweeps, B) Increasing shear strains, C) Increasing
frequencies

Indeed, during the time sweeps, all of the polymer solutions remained stable and
did not demonstrate large deviations in storage modulus over the duration of the
experiment (Figure 18A), which was expected from the previous results on the chemical
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modification of alginate (Fenn, Miao, et al., 2016; Miao et al., 2015). Considering chain
degradation was possible during the methacrylation and β-CD complexation chemical
reactions, the non-modified alginate materials should exhibit the highest shear storage
moduli (G′) values, decreasing in correlation with the polymer modifications. However, it
is interesting to note that the Alg-MA-β-CD solution recovered some of the viscoelastic
properties and displayed a higher G′ value than the Alg-β-CD. No major changes
occurred in the G′ values of any test samples during the radial strain sweep experiment,
confirming polymer solutions from 0.1 to 10% radial strain were relatively stable (Figure
18B). Between the 1 and 10 Hz frequency sweeps, the alginate and Alg-MA solutions
displayed sharp increases in G′ values. The Alg and Alg-MA-β-CD materials, however,
displayed a lesser dependence on frequency, demonstrating a more elastic response,
which may be attributed to the β-CD complexation and a stiffening of the alginate
backbone (Figure 18C).
Viscosity tests were performed on non-modified alginate, Alg-MA, Alg-β-CD, and
Alg-MA-β-CD polymer solutions (2%, w/v, 70 µL) at increasing shear rates at room
temperature.
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Figure 19: Rheological data for alginate controls (Alg) and chemically modified alginate (Alg-MA,
Alg-β-CD, Alg-MA-β-CD) measured at 25°C and 37°C to characterize the effects of chemical
modification on the viscosity of polymer precursor solutions prior to crosslinking.

Viscosity data collected on alginate (Alg), Alg-MA, and Alg-MA-β-CD polymer
solutions demonstrated that the chemical modifications of the backbone allowed for the
natural shear thinning behavior of alginate to be preserved. Shear thinning behavior was
observed at room temperature (25°C) and body temperature (37°C), for modified and
non-modified alginates, indicative of free-flowing polymer chains in solution. The results
indicated that the precursor solutions maintained injectability (Figure 19). It was
interesting to note that the viscosity values increased as the temperature increased from
25°C to 37°C. Normal material behavior (e.g. honey) would see viscosity decrease with
an increase in temperature. At higher shear rates, the viscosity values were nearly
identical for each polymer precursor solution at both temperatures. Since the higher
viscosity at a higher temperature occurred for both the unmodified and modified alginate
precursor solutions, it is assumed that this is a natural material property of alginate.
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3.5. Photo-Initiator Concentration Testing
For the green visible light crosslinking, it was hypothesized that varying the eosinY photo-initiator concentrations would alter the rate of crosslinking. Photo-initiator stock
solutions were prepared with 0.5% eosin Y (photosensitizer, EY) in 1-vinyl-2pyrrolidinone
(catalyst, 1VP) and 5 M triethanolamine (initiator, TEOA) in DI water
B
(Nettles et al., 2004; Park et al., 2003; Smeds & Grinstaff, 2001). The ratio (v/v) of
TEOA solution to alginate solution was varied, and the photo-initiator concentration was
increased from 1 to 40% (v/v). A 1:10 TEOA to eosin-Y ratio was held constant based on
previously reported photo-initiator concentrations (Fenn & Oldinski, 2016). Gelation
kinetics of the precursor solutions were assessed using an oscillatory time sweep at 1 Hz
and 10% radial strain. After 30 second at equilibrium, the precursor solutions were
exposed to visible green light (510 nm) for three minutes using a custom 9.84 cm
diameter light emitting diode (LED) array.

C

Figure 20: 2% Alg-MA-β-CD visible-light crosslinked with photo-initiator concentrations ranging
from 1 to 40%
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Photo-initiator concentrations ranged from 1 to 40%, and the final G′ values
decreased as the photo-initiator concentration increased. The highest G′ value for the
visible-light crosslinked compounds was for Alg-MA-β-CD with 1% photo-initiator at
700 Pa, as shown in Figure 20. The 5% photo-initiator concentration sped up crosslinking
to 20 seconds. The other tested concentrations included 2.5% for 30 seconds, 1% and
10% for 35 seconds, and 40% for 120 seconds. It was concluded that the 5% (v/v) TEOA
concentration resulted in the fastest crosslinking, which would be beneficial for a rapid
crosslinking in situ.
3.5.1. Effect of Visible Light Crosslinking on 4% Solutions
Oscillatory time sweeps were performed on Alg-MA and Alg-MA-β-CD solutions
(4%, w/v). Visible light crosslinking was performed for 10 minutes at 37°C, a frequency
of 1 Hz, and 1% radial strain. One minute after temperature equilibration, the polymer
solution was exposed to visible green light via a custom light emitting diode (LED) ring
placed around the rheometer geometry gap.
With the incorporation of photo-initiators, the methacrylated alginate materials
(Alg-MA and Alg-MA-β-CD) were expected to demonstrate G′/G″ crossover indicative
of hydrogel formation, as a result of covalent crosslinking. These experiments were
performed to verify that β-CD conjugation onto the Alg-MA material did not interfere
with the ability to crosslink upon exposure to visible green light.
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Figure 21: Gelatin kinetics for chemically modified alginate (Alg-MA and Alg-MA-β-CD) during
visible light exposure. Polymer solutions (4%, w/v) containing photo-initiators were exposed to
visible green light for 10 minutes; shear loss (G″) and storage (G′) moduli were calculated.

Both polymer solutions displayed liquid behavior before light exposure, and after
exposure to visible light. G′ increased and the crossover was determined to be the
gelation point for the two materials (Figure 21). Alg-MA-β-CD reached its gelation point
at 180 seconds compared with Alg-MA, which took approximately 350 seconds. In
addition, the Alg-MA-β-CD material exhibited a lower G′ value (18 kPa) after 10 minutes
of visible light crosslinking compared with Alg-MA, which reached a G′ value of nearly
35 kPa. The lower modulus for the Alg-MA-β-CD materials may be explained by
acrylate and β-CD interactions, as indicated by the increased viscosity after subsequent
methacrylation and β-CD conjugation, and a decreased availability of the acrylate groups
to form crosslinks.
3.5.2. Sequential Tri-Crosslinking Order Determination
In order to determine the sequence order for the tri-crosslinking hydrogel,
oscillatory temperature and time sweeps were performed on Alg-MA-β-CD with and
without a 1:1 weight ratio of Pluronic® F-127 solutions (2%, w/v). The sequential order
started with the weakest bonding (lowest storage moduli G’) and moved to the strongest
31

bonding (highest storage moduli G’) after exposure to a crosslinking method. The
temperature was increased from 25°C to 37°C, at a rate of 1°C/minute, 1% radial strain,
and a frequency of 1 Hz. Ionic crosslinking was performed for 10 minutes at 37°C, a
frequency of 1 Hz, and 1% radial strain. After temperature equilibration for one minute,
the polymer solution was exposed to 0.1 M CaCl2 solution (100 µL). Visible light
crosslinking was performed on polymer precursor solutions with the incorporation of
photo-initiators for 10 minutes at 37°C, a frequency of 1 Hz, and 1% radial strain. One
minute after temperature equilibration, the polymer solution was exposed to visible green
light via a custom light emitting diode (LED) ring placed around the rheometer geometry
gap.
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Figure 22: Gelation kinetics for chemically modified alginate Alg-MA-β-CD, with and without
Pluronic® F127, during temperature increase, ionic (0.1 M CaCl2), and visible light exposure

From this study it was found that the 2% Alg-MA-β-CD, when exposed to 0.1 M
calcium chloride, resulted in the highest storage modulus of 2498 Pa. The second highest
storage modulus (1531Pa) was found using 2% Alg-MA-β-CD after visible light
crosslinking with an eosin-Y photo-initiator system and visible green light. It is also
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important to note that the effects of the calcium chloride were seen directly after the
exposure, whereas the green light exposure had a 15 second delay before affecting the
storage modulus. The lowest storage modulus was found at the increased temperature for
the 2% Alg-MA-β-CD with a 1:1 weight ratio of Pluronic® F-127, only reaching a
storage modulus of 3 Pa. The temperature increase was expected to have the lowest
storage modulus, because the covalent bonds formed during the ionic and
photopolymerization crosslinking were stronger than the guest-host interactions between
the cyclodextrins and the Pluronics®.
3.5.2.1.Preliminary Crosslinking Order Reversal
Although it was determined that the tri-crosslinking order would be from lowest to
highest moduli, preliminary (single test) data was collected on the reversal of ionic and
photopolymerization crosslinking. The goal of this preliminary test was to ensure that the
hydrogel would still be able to further crosslink after either ionic or photopolymerization
preliminary crosslinking. Tests were run on 2% Alg-MA-β-CD (w/v) using an oscillatory
time sweep with the addition of the first crosslinking method (green light or 0.1 M CaCl2)
after one minute at equilibrium. After 10 minutes, the second crosslinking method was
used, and the final storage moduli values were measured after an additional 10 minutes of
crosslinking.
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Figure 23: Gelation kinetics for chemically modified alginate (Alg-MA-β-CD), reversing the order of
crosslinking between ionic (0.1 M CaCl2) and visible light exposure

It was found that 2% Alg-MA-β-CD (w/v) would result in a further increase in
storage moduli after a second crosslinking method when either ionic or
photopolymerization was used as the first crosslinking method. This was expected
because ionic crosslinking involves the carboxyl groups on the alginate backbone,
whereas photopolymerization involves chemically modified hydroxyl groups. The
increase in temperature was not included in the order reversal because it will always be
the first crosslinking method of the hydrogel when injected into the body from room
temperature.
3.5.3. Sequential Tri-Crosslinking of Alg-MA-β-CD Hydrogels
To investigate the effect of chemical modification and various external stimuli on
the mechanical properties of the alginate materials, control and experimental alginate
groups were exposed to heat, green light, and CaCl2 in a sequential fashion. Polymer
solutions (2%, w/v) included alginate (Alg) with and without a 1:1 weight ratio of
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Pluronic® F-127, Alg-MA with and without a 1:1 weight ratio of Pluronic® F-127, and
Alg-MA-β-CD with a 1:1 weight ratio of Pluronic® F-127. The temperature increased
from 25°C to 37°C, at a rate of 1°C/minute, 1% radial strain, and a frequency of 1 Hz.
One minute after temperature equilibration, the polymer solution was exposed to visible
green light via a custom LED ring. After 10 minutes of light exposure, the LEDs were
removed and 0.1 M CaCl2 (100 µL) was carefully added to the samples.

Figure 24: A) Gelation kinetics for 2% (w/v) alginate controls (Alg) and chemically modified alginate
(Alg-MA, Alg-MA-β-CD with and without F127) based on three sequential crosslinking methods: 1)
Increasing temperature to 37˚C, 2) Exposure to green light for 10 minutes, 3) Exposure to 0.1 M
CaCl2 B) The quantitative G′ values for the non-modified alginate controls, and chemically-modified
alginate hydrogels, showing the effect of three different sequential crosslinking techniques (mean ±
standard deviation, * p≤0.05, **p≤0.01)
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The sequential tri-crosslinking of chemically-modified alginate materials was
successful in forming tri-network hydrogels, as shown by the increasing shear storage
modulus (G′) in Figure 24. All of the polymer solutions used in this experiment were 2%
(w/v), and at this concentration, all three crosslinking techniques had an effect on the
rheological properties of the novel material, Alg-MA-β-CD. There was a significant
increase in G′ for the alginate group after exposure to green light (from 2.8 Pa to 4.4 Pa),
but this may have been caused by the dehydration of the alginate sample on the
rheometer, as the LEDs produce heat. For the alginate control solutions, there was also a
significant increase in G′ with the addition of CaCl2, from 4.4 Pa to 17.6 kPa. For the
Alg-MA polymer solution, there was a significant increase in G′ after exposure to green
light, and the subsequent addition of CaCl2 (Figure 24A, gray circles). It was expected
that the Alg-MA group would exhibit a significantly larger increase in G′ after exposure
to green light, given that covalent crosslinking occurs between acrylate groups with the
photo-initiators in solution. Indeed, the moduli increased from 0.75 Pa to 2.7 kPa, and
after ionic crosslinking, G′ increased to 18.0 kPa. For the Alg:F-127 and Alg-MA:F-127
blends (Figure 24A: white triangles and gray diamonds, respectively), there was no
significant increase in G′ with increasing temperature. However, as expected, there was a
statistically significant increase in G′ with the addition of CaCl2 for the Alg:F-127. After
green light exposure the Alg:F-127 and Alg-MA:F-127 blends had final G′ values of 15.4
kPa and 22.8 kPa, respectively. For the Alg-MA-β-CD:F-127 hydrogel, there was no
significant increase in G′ with increasing temperature (Figure 24A, black circles),
possibly due to the relatively low amount of F-127 in the hydrogel. F-127 was chosen for
the sequential crosslinking experiment, due to its lower liquid-gel transition temperature,
providing improved stability prior to visible light crosslinking.
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As indicated by the Alg-MA-β-CD:F-127 hydrogel group, the hydrogel was able to
sequentially increase stiffness via applied heat, visible light exposure, and the addition of
calcium salt, after a physical interaction and a supramolecular network was formed. In
addition, the effect of the β-CD functional group enhanced the thermo-responsive effect
of the Pluronic® copolymer. As shown in Figure 24, Alg and Alg-MA showed little
change in modulus with the addition of the Pluronic®, though the Alg-MA-β-CD group
demonstrated an increasing modulus with an increase in temperature. The increase in
modulus with the Alg-MA-β-CD:Pluronic® hydrogel was not significant, but this could
be further enhanced by either increasing the weight ratio of Pluronic®, or increasing the
overall concentration of the polymers in solution, which was examined next.
3.5.4. Effect of Pluronic® Selection and Alg-MA-β-CD Polymer Concentrations
To investigate the effect of using two different Pluronic® copolymers, F-108 and
F-127, as well as two different Alg-MA-β-CD polymer solution concentrations, 2% and
4% (w/v), various polymer blends were prepared (1:1 Alg-MA-β-CD:Pluronic® weight
ratio). The resulting supramolecular hydrogels were equilibrated for 24 hours prior to
rheological testing. Temperature increase crosslinking was performed following the
experimental protocol detailed in the above sequential crosslinking section. The effect of
crosslinking temperature (i.e., liquid-gel transition temperature) was analyzed, and the
final storage moduli after crosslinking were compared.
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Figure 25: Gelation kinetics for 2% and 4% (w/v) Alg-MA-β-CD, blended with either Pluronic® F108 or Pluronic® F-127, were determined to verify chemical functionalization and controlled
crosslinking based on increasing temperature to 37˚C (mean ± standard deviation, n = 3, * p≤0.05,
**p≤0.01)

Selection of pre-curser molecules and polymer density (i.e., concentration) played
a significant role in hydrogel stiffness. Both the polymer concentration and Pluronic®
selection had an impact on the G′ of the chemically modified alginate hydrogels, which
increased as expected. Figure 25 shows the quantitative impact of increasing the polymer
solution from 2% to 4% (w/v) and changing the Pluronic® component from Pluronic® F108 to Pluronic® F-127. Indeed, the overall shear stiffness and the thermoresponsiveness both increased with increasing polymer concentration. G′ values, after the
increase in temperature was applied, for 2% (w/v) Alg-MA-β-CD:Pluronic® hydrogels,
decreased from 0.32 Pa to 0.25 Pa for F-108 blends and increased from 1.02 Pa to 3.02
Pa for F-127 blends. Upon switching to a 4% (w/v) polymer concentration, G′ values,
after the increase in temperature was applied, increased from 7.74 Pa to 24.31 Pa and
28.95 Pa to 233.1 Pa for F-108 and F-127 blends, respectively. It was found that using
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Pluronic® F127 resulted in higher storage moduli values for both the 2% and 4%
polymer concentrations. The Pluronic® F127 was determined to be more desirable for
stronger crosslinking upon injection into the body when the polymer precursor solution
increases from room temperature (25°C) to body temperature (37°C).
3.5.5. Sequential Tri-Crosslinking of 2% and 4% Alg-MA-β-CD+F108/127
To investigate the tri-crosslinking effect of using two different Pluronic®
copolymers, F-108 and F-127, and two different Alg-MA-β-CD polymer solution
concentrations, 2% and 4% (w/v), various polymer blends were prepared (1:1 Alg-MA-βCD:Pluronic® weight ratio). The resulting supramolecular hydrogels were equilibrated
for 24 hours prior to rheological testing, and tri-crosslinking was performed following the
experimental protocol detailed in the above sections.
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Figure 26: A) Gelation kinetics for 2% and 4% (w/v) Alg-MA-β-CD, blended with either Pluronic®
F-108 or Pluronic® F-127, were determined to verify chemical functionalization and controlled
crosslinking based on three sequential crosslinking methods: 1) Increasing temperature to 37˚C, 2)
Exposure to green light for 10 minutes, 3) Exposure to 0.1 M CaCl2 B) The quantitative G′ values for
the non-modified alginate controls and chemically-modified alginate hydrogels showing the effect of
three different and sequential crosslinking techniques (mean ± standard deviation, * p≤0.05,
**p≤0.01)

The quantitative G′ values for the Alg-MA-β-CD:Pluronic® hydrogels are shown in
Figure 26. The 4% (w/v) tri-crosslinked Alg-MA-β-CD:F-127 hydrogels achieved the
highest stiffness of 32.67 kPa. The results from these studies proved that by using one, or
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all three, crosslinking technique(s), the hydrogel’s mechanical properties can be easily
tuned for numerous tissue engineering applications, ranging from 0.2581 Pa to 32.67 kPa.
3.6. Conclusion
The chemical modifications to the alginate backbone preserved the natural shear
thinning properties of alginate, allowing for the material to be injectable. It was
determined that using a 5% (v/v) TEOA and 0.5% (v/v) eosin Y concentrations of the
stock photo-initiators resulted in crosslinking of the hydrogel in under 30 seconds. The
order of tri-crosslinking was determined by the lowest storage moduli (temperature
increase; 3 Pa) to the highest storage moduli (calcium chloride exposure; 2498 Pa), with
photopolymerization storage moduli in the middle (at 1531 Pa). Preliminary results also
proved that the storage moduli would increase as the hydrogel was exposed to calcium
chloride before photopolymerization, which was expected since the crosslinking methods
used different functional groups. It was found that using Pluronic® F127 resulted in a
stronger supramolecular interaction between the β-cyclodextrin cavity and the negative
segment of the tri-block co-polymer upon temperature increase. The mechanical
properties of Alg-MA-β-CD and Pluronics® during sequential crosslinking can be seen
in Figure 27.
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Tunability of the Storage Modulus for Tri-Crosslinking Hydrogel (Pa)
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Figure 27: Tunability of the storage modulus (Pa) for tri-crosslinking hydrogels

It is important to note that all three crosslinking methods used to create this tricrosslinking alginate-based hydrogel are non-UV dependent. As discussed earlier, UVlight can be damaging to cells, drugs, or proteins encapsulated in the hydrogel. Using
visible green light (510 nm), rather than UV-light, for photopolymerization should allow
for the encapsulation of viable cells, which was tested in the subsequent chapter.
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4.

CHAPTER 4: TRI-STIMULI RESPONSIVE HYDROGEL CELL
ENCAPSULATION
4.1. Introduction

Tissue engineering has shown promise in creating simple tissue structures;
however, a number of challenges remain in engineering the complex, hybrid tissues with
gradient properties in vitro (Martin et al., 2007; P. J. Yang et al., 2009). As an alternative
to laboratory-based tissue engineering, mesenchymal stem cell (MSC) therapy is an
attractive option, which allows the body to aid in cell differentiation, matrix production,
and tissue regeneration in situ (Spees et al., 2016). MSC encapsulation and in situ
delivery within hydrogels are attractive methods for healing and restoring
damaged/diseased tissue, as compared to in vitro tissue scale up, due to the ease of
application and reduced production costs (Noth et al., 2008; Rodriguez-Fontan et al.,
2017). More specifically, hydrogel physico-mechanical properties have been studied to
maintain or direct cell phenotype, in addition to assisting the paracrine effect from cells
releasing growth factors and proteins into surrounding tissues (Guilak et al., 2000; Yuan
et al., 2017). Over the last decade, the use of human MSCs in clinical trials has been on
the rise (Oppermann et al., 2014). There have been numerous medical products approved
by the Food and Drug Administration (FDA) that use human MSCs, such as OsteoCel for
spinal bone regeneration and Grafix for repairing soft tissue defects (Jossen et al., 2018).
With the increasing use of human MSCs, there is a need to develop biomaterial
platforms, such as hydrogels, to deliver and maintain viable MSCs in vivo, while
mimicking soft tissue physico-mechanical properties to restore natural tissue function.
Hydrogels, consisting of crosslinked networks of polymers, are utilized as threedimensional (3D) networks to enable tissue regeneration with varying innate structure43

function relationships (Vega et al., 2017). Hydrogels can be formulated as injectables,
bulk materials, pre-formed microspheres, or microspheres formed in situ, all with
capabilities of encapsulating MSCs (Jeon et al., 2015; Xin Zhao et al., 2016).
Furthermore, hydrogel biochemistry, controlled bioactivity, and physical / mechanical
properties have been documented in order to regulate stem cell fate and activity (i.e.,
tissue regeneration and/or repair) (Chaudhuri et al., 2016; Dennis E Discher et al., 2005;
Dennis E. Discher et al., 2009; Engler et al., 2006; Lutolf et al., 2009).
The biomedical field has a substantial interest in developing and applying
homogeneous alginate microspheres for stem cell microencapsulation. Microfluidics is an
expanding field, due to the precise control capabilities afforded by using small portions of
material (Rossow et al., 2017; Velasco et al., 2012). Microfluidic flow focusing devices
(MFDs) allow multiple experiments to be performed on small scales with accurate
metering capability. The field of microfluidics applies directly to chemical synthesis,
biological analysis, optics, and information technology, but more relevantly, it also
applies to the development of homogeneous hydrogel microspheres in the range of 101000 µm. Microspheres are manufactured using mixing emulsions on stir plates at high
speeds, which form colloids or using the fine particles sprayed from atomizers. However,
the resulting microspheres are not homogenous in size and thus limit predictable cell
encapsulation. The ability to utilize visible-light crosslinking techniques on βcyclodextrin-modified alginate for stem cell encapsulation in microspheres has yet to be
verified within the literature.
4.2. Materials
Sodium alginate (PROTANAL® LF200 FTS, Mv = 67−142 kg/mol) was kindly
donated by FMC Biopolymer. Methacrylic anhydride, CaCl2, N-ethyl-N’(344

dimethylaminopropyl) carbodiimide hydrochloric acid (EDC), N-hydroxysuccinimide
(NHS), Pluronic® F-108 [poly(ethylene glycol)-block-poly(propylene glycol)-blockpoly(ethylene glycol) (PEG-b-PPG-b-PEG), Mn = 15 kg/mol], Pluronic® F-127
[poly(ethylene oxide)-block-poly(propylene oxide)-block-poly(ethylene oxide) (PEO-bPPG-b-PEO), Mn = 13 kg/mol], triethanolamine, eosin Y, and 1-vinyl-2-pyrrolidinone
were purchased from Sigma Aldrich. β -cyclodextrin (β-CD), ρ-toluenesulfonyl chloride
(TosCl), acetonitrile, acetone, and ethylenediamine (EDA) were purchased from Acros
Organics. Sodium hydroxide (NaOH), hydrogen chloride (HCl), phosphate buffered
saline (PBS), the 2-morpholinoethanesulfonic acid (MES) buffer, and alpha-modified
eagle medium (α-MEM, Hyclone) were purchased from Thermo Fisher Scientific.
Primary human MSCs, derived from bone marrow, were purchased from Rooster Bio.
Human MSC-screened fetal bovine serum (FBS) was purchased from Atlanta Biologics.
Penicillin, streptomycin, and trypsin ethylenediaminetetraacetic acid (EDTA) were
purchased from Corning Cellgro.
4.3. Hydrogel Encapsulation of Human MSCs
In this study, a methacrylated and β-CD-modified alginate hydrogel was fabricated
and investigated for use in the delivery and 3D culturing of primary human MSCs. It was
hypothesized that the injectable modified alginate hydrogels enable various methods of
controlled crosslinking and maintain the viability of encapsulated MSCs during needle
ejection and subsequent crosslinking via calcium chloride or photopolymerization.
4.3.1. MSC Culturing
MSCs were seeded in T75 tissue culture flasks at a density of 0.3x106 cells per flask,
in 10 mL of standard MSC growth media (alpha minimum essential medium supplemented
with 10% FBS, 100 U mL-1 penicillin, and 100 mg mL-1 streptomycin). The flasks were
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cultured at 37°C, using 5% CO2 until 80% confluent. MSCs were expanded to create a
stock solution of 106 cells/mL (passage 6).
4.3.2. Bulk Encapsulation
Alg-MA-β-CD was premixed with and without Pluronic® F-127 to form hydrogels;
mixed solutions were equilibrated in complete darkness at room temperature for 48 hours
before testing. The stock cell solution (200 µL, 20x105 MSCs) was carefully added to the
2% (w/v) polymer solutions of Alg-MA-β-CD and Alg-MA-β-CD:Pluronic® (1:1 weight
ratio), and centrifuged for one minute at 563 g-force to remove air bubbles. Polymer
solutions and shear-thinning hydrogels encapsulating MSCs were ejected from a syringe
through an 18 G needle into a 35 mm tissue culture dish to form 3 mm thick 3D hydrogel
samples. The materials were then exposed to green light or 500 µL of 0.1 M CaCl2 for 10
minutes, and were then covered with 1 mL of MSC standard growth medium. For ionically
crosslinked hydrogels, the CaCl2 was aspirated off before the addition of the standard
growth medium. Hydrogels containing MSCs were incubated for 48 hours in static
conditions at 37°C with 5% CO2.
4.3.3. MSC Characterization
Material selection for cell encapsulation was based on the preceding rheological
experiments in Chapter 3. The Pluronic® F-127 crosslinked at a lower temperature than
the F-108, ensuring a higher degree of crosslinking at body temperature. Thus, F-127 and
Alg-MA-β-CD were chosen to form a hydrogel from which a rigorous viability study for
encapsulated MSCs could be performed. A 2% polymer concentration was chosen to
decrease the density of the polymer in the hydrogel, allowing for higher theoretical
nutrient diffusion for encapsulated MSCs, as compared with the 4% hydrogel.
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Viability assays were performed after 48 hours; a live/dead viability/cytotoxicity
kit (Molecular Probes) with excitation/emission levels for green (494 nm/517 nm) and
red (528 nm/617 nm) was used to qualitatively determine MSC viability after mixing,
ejection, and culturing at 37°C with 5% CO2. The live/dead assay indicated viable cells
with a green fluorescence and dead cells with a red fluorescence. This is due to the
ethidium homodimer-1 chemical (red fluorescence) entering the nucleus of a dead cell
through the damaged cell membrane, which cannot be entered through a living cell
membrane.

Living Cells

Dead Cells

Figure 28: Live/dead assay indicating living (green) and dead (red) cells

Under reduced lighting, one vial of ethidium homodimer-1 was added to one vial
of calcian AM. Growth medium was removed from the petri dishes and 200 µL of the
live/dead solution was added. Hydrogel stains were incubated with the live/dead stain for
30 minutes. A fluorescence microscope (Olympus BX53) was used to image the
live/dead fluorescent stain under 10x magnification. Images were collected using
CellSens software.
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Live Stain

Phase Contrast

Dead Stain

Alg-MA-!-CD
(0.1M CaCl2)

Alg-MA-!-CD
(Visible Light)

Alg-MA-!-CD + F-127
(Visible Light)

Figure 29: Human MSCs were encapsulated within Alg-MA-β-CD solutions and Alg-MA-βCD:Pluronic-F127® hydrogels (1:1 weight ratios), and ejected through an 18 G syringe. A live/dead
viability/cytotoxicity kit was used to qualitatively determine MSC viability after mixing, ejection, and
post ionic/photopolymerization after a 48-hour culture within the 3D hydrogels at 37°C, 5% CO2.
Fluorescent microscopy images were captured at 10x magnification; left = phase contrast image,
middle = green indicates viable cells, right = red indicates dead cells. Scale bar = 200 µm.

Qualitatively, the polymer solution containing F-127 had more initial resistance
when ejecting due to guest-host interactions between the β-CD functional group and the
F-127 hydrophobic PPO block. Both the 2% Alg-MA-β-CD solution and the 2% AlgMA-β-CD:F-127 hydrogel encapsulated MSCs throughout the hydrogels, and prevented
cells from sinking to the bottom of the culture dish prior to ionic or crosslinking under
green light. After 48 hours of incubation, MSCs retained viability in the hydrogels,
suggesting that the hydrogels can support MSC activity and allow for cells to release
proteins and growth factors into surrounding tissues.
The combination with F-127 may result in a slightly more cytotoxic hydrogel, as
seen by the qualitative increase in the number of dead (red) cells when compared with
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Alg-MA-β-CD without F-127 (Figure 29). From hand counting imaged cells (n=2), it was
found that the ionically crosslinked Alg-MA-β-CD had ~80% cell viability, the visible
light crosslinked Alg-MA-β-CD had ~60% viability, and the Alg-MA-β-CD+F127 had
the lowest viability at ~55%. The toxicity of F-127 has previously shown adverse effects
on cells at higher (10%) concentrations, so although unexpected at the lower
concentration, the combination of the 2% Alg-MA-β-CD and 2% F-127 showed slightly
higher toxic effects (Khattak et al., 2005). The eosin-Y photo-initiator system has shown
cytotoxic effects, such that decreasing the concentration may enhance cell viability (C.
Bahney et al., 2011). In addition, the photo-initiator system caused higher background
fluorescence during imaging, as seen in the visible light crosslinked hydrogels, which
made cell counting challenging.
4.4. Microsphere Formation and MSC microencapsulation
The use of visible light and ionic crosslinking were examined in more detail;
specifically, the effects of stem cell viability post microencapsulation in modified
alginate hydrogels were investigated using a microfluidic device. The critical aspect of
this work is the applicable use of an alternative, less harmful, wavelength of light,
compared to UV, in vitro with cells, or in situ with or without encapsulated cells (C. S.
Bahney et al., 2011).
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Figure 30: Schematic of microfluidic flow focusing device using modified alginate solutions (green)
and mineral oil (yellow) for microsphere cell encapsulation with photopolymerization and ionic
crosslinking

4.4.1. MSC Culture
Frozen primary human MSCs (bone-marrow derived, Rooster Bio) were
resuspended in 1.5 mL of growth media (alpha modified eagle medium supplemented
with 10% fetal bovine serum, 100 U mL-1 penicillin, 100 mg mL-1 streptomycin). 500
µL of this cell suspension was added to three T75 flasks and cultured at 37°C with 5%
CO2. After one day, the growth media was replaced. At 90% confluency, cells were
passaged; MSCs were used at passage 5.
4.4.2. MSC microencapsulation
A 2% (w/v) Alg-MA-β-CD solution in cell media was selected for cell
encapsulation, which required 0.8 mL of cell media and 0.02 g of lyophilized Alg-MA-βCD followed by the addition of photo-initiators. 50 µL of 5 M TEOA (5% (v/v)) was
added to the polymer solution and mixed thoroughly before 5 µL of eosin-Y in VP
solution (0.5% (v/v)) was added. A polymer solution with a cell density of 2 million
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cells/mL was prepared and transferred to a 1 mL lure lock syringe. A 2% (v/v) Span 80
oil solution was dispensed from a 10-mL syringe. The syringes were locked into PDH
2000 Infusion syringe pumps and secured to the holes placed at the inlet and exit points
of the MFD. A desired droplet size of 150 µm was chosen, and from previous experience,
a dispersion flow of 0.0004 mL/min and a continuous flow of 0.008 mL/min were chosen
to obtain the desired microsphere size.
Four different methods of microsphere crosslinking were investigated in this study
to examine the effects on MSC viability. For the first crosslinking method, the emulsion
beads were dropped directly into a microcentrifuge tube containing 1 M CaCl2 solution
and then collected. The formed microspheres were captured and washed from the mineral
oil through the addition of isopropyl alcohol followed by centrifuging at 1690 g-force for
one minute. The microspheres were washed in isopropyl alcohol and centrifuged two
more times, followed by three washes in DI water. The second crosslinking method
consisted of dropping the emulsion beads leaving the MFD into a microcentrifuge tube
containing cell culture media, and after 30 minutes of collecting microbeads, the green
LED light was activated for five minutes to crosslink the microspheres. The third
crosslinking method consisted of dropping the emulsion beads into a microcentrifuge
tube containing 0.01 M CaCl2 solution, and after 30 minutes of collection, the green LED
light was activated for five minutes to crosslink the microspheres. The fourth crosslinking
method consisted of 30 minutes of collection into a microcentrifuge tube containing cell
media, then the green LED light was activated and applied intermittently (30 second
on/off cycles) for five minutes to crosslink the microspheres.
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4.4.3. MSC Viability Post Microencapsulation
To test the viability of cells encapsulated within Alg-MA-β-CD via the MFDs, a
live/dead cell imaging kit (Molecular Probes) was prepared and used according to the
manufacturer’s instructions. The cells were stained for 15 minutes at 25°C and then
transferred to a hemocytometer. The hemocytometer was inserted into a Countess II
automated cell counter (Invitrogen), with light cubes (Invitrogen) GFP (Ex/Em 470/510
nm) and RFP (Ex/Em 531/593 nm) to fluoresce the stains and cells within the
microspheres, as imaged below.

Figure 31: Images of MSC-encapsulating Alg-MA-b-CD microspheres produced in MFDs. (A) 1 M
CaCl2 crosslinking solution, (B) Cell media collected followed by green light crosslinking 30 minutes
post collection, (C) Continuous green light crosslinking after collection in a 0.1 M CalCl2 bath, (D)
Cell media collected with intermittent green light crosslinking. These images were obtained ~one
hour after the cells were added to the Alg-MA-b-CD solution and crosslinked. The different filtered
images represent: a.) Bright field view, b.) GFP light cube, c.) RFP light cube, d.) Magnified image of
dead (red fluorescent) encapsulated cells.
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The MFD generated micro-drops of 2% Alg-MA-β-CD encapsulating MSCs. As
expected, the high calcium chloride concentration (1 M) collection bath mixture with cell
media decreased MSC viability inside the microspheres. Figure 31A confirms the red
fluorescence of the dead stain in cells encapsulated by a microsphere. The second
experiment was the same, except the collection bath contained only cell media. After 30
minutes of collection, the green LED light was activated to crosslink the microspheres.
Upon viewing the fluorescent images, it was evident that the MSCs were washed out of
the Alg-MA-β-CD drops (Figure 31B). What was left in the bottom of the bath was a
combination of live and dead free floating MSCs.
The next experiment was run with continuous green light. This time 0.4 M CaCl2
was added to the collection bath. Instead of having isopropyl alcohol wash the oil away
from the microspheres, the collection tubes were centrifuged at 563 g-force for one
minute. Live cells were found inside the 2% Alg-MA-β-CD microspheres (Figure 31C).
The fourth crosslinking method consisted of 30 minutes of collection, and then the green
LED light was activated and applied intermittently for five minutes (30 second on/off
cycles) to crosslink the microspheres. 2% Alg-MA-β-CD microspheres were crosslinked
and preserved through the washing steps. The MSCs were viable within the alginate
hydrogel (Figure 31D).
4.5. Conclusion
To advance tissue repair in situ, it is necessary to develop viscoelastic hydrogels that
recapitulate native soft tissue properties, in order to improve MSC therapy efficacy and
ultimately control and optimize soft tissue regeneration. Chemically-modifiable and
mechanically tunable natural materials, such as modified alginate, show promise as MSC
carriers for soft tissue regeneration and/or repair. Pilot MSC viability experiments were
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conducted to demonstrate MSC retention after ejection from a syringe or encapsulation in
microspheres with ionic and/or photopolymerization crosslinking as well as a short-term
in vitro culture period. MSCs were mixed within 2% (w/v) Alg-MA-β-CD solutions, with
and without a 1:1 ratio of F-127, and were successfully ejected through an 18 G needle to
be encapsulated within alginate hydrogels. After 48 hours of incubation, MSCs retained
viability in the hydrogels, suggesting that the hydrogels can support MSC activity. In
addition, combinations of visible green light and low calcium chloride concentrations
resulted in viable MSCs encapsulated in 2% (w/v) Alg-MA-β-CD microspheres.
Crosslinking a microsphere bead with visible light as it formed prevented coalescence
and deformation of the bead when dropping into a collection bath containing a low
concentration of calcium chloride.
Ideally, the hydrogel systems would have 100% cell viability to allow for maximum
cell paracrine effects or differentiation into desired cell types, but this has not been
achieved with the polymer and photo-initiator combination. Although 48 hours after bulk
encapsulation and hours after microsphere encapsulation viable cells remined, additional
optimization is needed to increase cell viability, specifically in regard to the use of
Pluronics® and alterations in the photo-initiator concentrations. Indeed, supplementary
experiments with longer time periods and different excitation/emission wavelengths will
need to be performed to further investigate this hypothesis. Furthermore, functional
modifications, such as adhesion ligands, will improve the viability and MSC activity
within Alg-MA-β-CD based hydrogels.
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5.

CHAPTER 5: MODIFYING MECHANICAL PROPERTIES
5.1. Introduction

Injectable hydrogels are ideal for cell delivery, due to the promotion of homogenous
cell distribution throughout the hydrogel (Wang & Chen, 2016). The mechanical
properties of the hydrogel can also be altered, thus altering the biomechanical stimulus to
the encapsulated cells. As previously mentioned, the extracellular matrix, which serves as
the scaffolding for tissues within the body, is a viscoelastic material (Andrea Zieris et al.,
2010). The extracellular matrix not only has an effect on cell proliferation and
differentiation, but also on the structure and strength of the resulting tissue (Shoichet et
al., 1996). The mechanical properties of a substrate (e.g. stiffness) have been shown to
have a greater effect on the growth of a cell than chemical stimuli (Janmey & Schliwa,
2008). Biophysical properties within the body are very diverse, varying from soft brain
tissue (1 kPa stiffness) to hard bone tissue (20 GPa stiffness) (C. M. Murphy et al., 2012).
The storage modulus values of several hydrogels used in tissue engineering can be seen
in Table 1.
Table 1: Previously studied hydrogel uses and storage modulus values

Hydrogel Base
Material

Paper Title

Hydrogel
Use

G’

Source

Alginate

Improving Viability of
Stem Cells During
Syringe Needle Flow
Through the Design of
Hydrogel Cell Carriers
Disulphide crosslinked
star block copolypeptide
hydrogels: influence of
block sequence order on
hydrogel properties
Enzymatically
Degradable MusselInspired Adhesive
Hydrogel
Graphene/gelatin
hydrogel composites with

Improve cell
viability
during
injection

29.6 Pa

(Aguado et
al., 2011)

Drug
delivery

820 Pa 4530 Pa

(R. D.
Murphy et
al., 2018)

Medical
sealants or
glues

~ 10 kPa

(Brubaker et
al., 2011)

Electroactive
polymers

2.56 × 105 1.61 x106

(Tungkavet
et al., 2015)

Star shaped
diblock
copolypeptides
Poly(ethylene
glycol) (PEG)
Graphene/
gelatin
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Fiber-reinforced
poly(ethylene
oxide) (PEO)
Alginate

Chitosan

Poly(ethylene
glycol) (PEG)
Poly(ethylene
glycol) (PEG) &
Fibrinogen

Glycopolypeptide

Gelatin

Gelatin

ABC triblock
copolypeptoids

high storage modulus
sensitivity for using as
electroactive actuator:
Effects of surface area
and electric field strength
In Situ Fabrication of
Fiber Reinforced ThreeDimensional Hydrogel
Tissue Engineering
Scaffolds
Polysaccharides based
injectable hydrogel
compositing bio-glass for
cranial bone repair
High encapsulation and
localized delivery of
curcumin from an
injectable hydrogel
Production of heparincontaining hydrogels for
modulating cell responses
The effect of matrix
stiffness of injectable
hydrogels on the
preservation of cardiac
function after a heart
attack
Injectable
glycopolypeptide
hydrogels as biomimetic
scaffolds for cartilage
tissue engineering
Modulation of
chondrocyte functions
and stiffness-dependent
cartilage repair using an
injectable enzymatically
crosslinked hydrogel with
tunable mechanical
properties
The effect of injectable
gelatinhydroxyphenylpropionic
acid hydrogel matrices on
the proliferation,
migration, differentiation
and oxidative stress
resistance of adult neural
stem cells
Thermoreversible and
injectable ABC
polypeptoid hydrogels:

Fibroblast
differentiatio
n into
osteoblasts

2.5 and
27.4 MPa

(Jordan et al.,
2017)

Cranial bone
repair

~4000 Pa 4500 Pa

(Bai et al.,
2017)

Chemotherap
y delivery
systems

~3000 Pa

(Ning et al.,
2018)

Cardiovascul
ar
applications
Heart study

0.4 - 2.8
kPa

(Nie et al.,
2009)

83-1800 Pa

(Plotkin et
al., 2014)

Cartilage
engineering

1280 5030 Pa

(Ren et al.,
2015)

Cartilage
repair

569 - 2746
Pa

(L.-S. Wang
et al., 2014)

Neural tissue
in adult
brains

400 -1000
Pa

(Lim et al.,
2012)

Tunable
hydrogels in
general

0.5 -2346
Pa

(Xuan et al.,
2016)
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controlling the hydrogel
properties through
molecular design

Methacrylated alginate (Alg-MA) was used in the following studies as the base
material to test the mechanical tunability of the hydrogels. Changes were made either
during the synthesis process or in the formulation of components used. For each test
described below three or more experimental trials were conducted and averages were
reported unless otherwise stated.
5.2. Materials
Sodium alginate (PROTANAL® LF200 FTS, Mv = 67−142 kg/mol) was donated
by FMC Biopolymer. Methacrylic anhydride, calcium chloride (CaCl2), triethanolamine,
eosin Y, and 1-vinyl-2-pyrrolidinone were purchased from Sigma Aldrich. Sodium
hydroxide (NaOH), phosphate buffered saline (PBS), and the 2morpholinoethanesulfonic acid (MES) buffer were purchased from Thermo Fisher
Scientific. Photo-initiator stock solutions were prepared with 0.5% eosin Y
(photosensitizer, EY) in 1-vinyl-2-pyrrolidinone (catalyst, 1VP) and 5 M triethanolamine
(initiator, TEOA) in DI water.
5.3. Effects of Light Exposure on Crosslinking
The effect of light exposure duration on an Alg-MA hydrogel was determined to
verify that the longer the material was exposed to green light, the higher the storage
modulus would be, eventually reaching a plateau. Alg-MA polymer solutions (2%, w/v)
and photo-initiators (5% v/v TEOA and 0.5% Eosin Y) were prepared with degrees of
modification (DOM) of 1.2% for the acrylate group. Gelation kinetics of the Alg-MA
precursor solutions were assessed using an oscillatory time sweep at 1 Hz and 10% radial
strain. After 30 seconds of temperature equilibrium, the material was exposed to visible
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green light using a custom 9.84 cm diameter light emitting diode (LED) array for 2, 4,
and 8 minutes. After 2, 4, and 8 minutes of exposure, the green light was turned off and
the oscillatory data was collected for a total of 10 minutes.

2 Minutes Light Exposure
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Figure 32: Green light crosslinking for two minutes
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Figure 33: Green light crosslinking for four minutes
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8 Minutes Light Exposure
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Figure 34: Green light crosslinking for eight minutes

The exposure time of green light to the hydrogel precursor solution allowed for the
material to be tuned. The storage moduli were 140 Pa for two minutes of exposure, 494
Pa for four minutes of exposure, and 1210 Pa for eight minutes of exposure. It is
important to note that there was still a slight increase in storage moduli that continued
after removing the green light, but the photopolymerization stops with the removal of the
light.
5.4. Effects of Degree of Modification on Crosslinking
During the synthesis process of methacrylated alginate, the degree of modification
of the acrylate group was altered between 1 and 4% for low modification and 4 and 8%
for high modification. It was hypothesized that increasing the degree of modification
would increase the storage modulus of the material, due to the increased number of
acrylate groups for the photo-initiator system to bond with. Alg-MA polymer solutions
(2%, w/v) and photo-initiators (5% v/v TEOA and 0.5% eosin Y) were prepared with
methacrylated alginates at two degrees of modification (DOM): 1.2% and 4.6%. Gelation
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kinetics of the different DOM Alg-MA precursor solutions were assessed using an
oscillatory time sweep at 1 Hz and 10% radial strain. After 30 seconds of temperature
equilibrium, the solutions were exposed to visible green light using a custom 9.84 cm
diameter light emitting diode (LED) array for 10 minutes. Shear storage moduli (G′) were
calculated using analytical software (TA Data Analysis).

2% Alg-MA
Varying Degrees of Modification

10000

** ** *
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Figure 35: Gelation kinetics of the different DOM Alg-MA precursor solutions (mean ± standard
deviation, * p≤0.05, **p≤0.01)

It was expected that by increasing the degree of modification from 1.2% to 4.6% a
larger difference in storage modulus would be found, due to the increased number of
available acrylate groups, which should increase crosslinking strength. There were
significant differences between the 1.2% DOM and 4.6% DOM during the lower green
light exposure times (two to five minutes). Although the increase in DOM for Alg-MA
showed significant increases for short exposure times (two to five minutes), the storage
moduli were not significantly higher for longer exposure times (six to 10 minutes). The
additional acrylate groups explain why the 4.6% DOM material was able to crosslink
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faster than the 1.2% DOM, but it is interesting to note that both groups reached similar
storage moduli with exposure times greater than five minutes. In order to ensure rapid
crosslinking in situ, it is beneficial to use the higher DOM of the acrylate group on the
alginate backbone.
5.5. Effects of Polymer Concentration on Crosslinking
As previously seen with the tri-crosslinking hydrogel (Alg-MA-β-CD), polymer
concentration had an effect on the final storage moduli values. In this study, only the
effect on methacrylated alginate was investigated when exposed to visible green light.
Alg-MA polymer (DOM 4.6%) solutions of two different concentrations 2% and 4%
(w/v) with photo-initiators (5% v/v TEOA and 0.5% eosin Y) were prepared in PBS.
Gelation kinetics of the different polymer concentration precursor solutions were
assessed using an oscillatory time sweep at 1 Hz and 10% radial strain. After 30 seconds
of temperature equilibrium, the solution was exposed to visible green light using a
custom 9.84 cm diameter LED array for nine minutes. Shear storage moduli (G′) were
calculated using analytical software (TA Data Analysis).
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Figure 36: Gelation kinetics of varying polymer concentrations (2% and 4%) (mean ± standard
deviation, * p≤0.05, **p≤0.01)

As expected, the increase in polymer concentration from 2% w/v to 4% w/v caused
an increase in storage modulus. The hydrogel precursor solution’s initial storage modulus
increased from 34 Pa to 280 Pa. After nine minutes of exposure to visible green light, the
storage modulus of the hydrogel increased from 1592 Pa (2% concentration) to 5827 Pa
(4% concentration). There was a statistically significant difference between the 2% and
the 4% polymer concentration at each timepoint between zero and nine minutes. This
result indicates that the polymer concentration has a large influence on the final storage
moduli.
5.6. Effect of Photo-Initiator Concentration on Crosslinking
As previously discussed, the photo-initiator concentrations were chosen with a 1:10
ratio of stock eosin-Y-to-TEOA based on previous literature. It was hypothesized that
altering both the eosin-Y and TEOA component in the hydrogel would result in varying
storage moduli values. The concentrations of the stock eosin-Y and TEOA solutions were
chosen based on the ratio that resulted in the highest storage moduli. Additional
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considerations were taken into account to reduce cytotoxicity of the photo-initiator
system, as discussed in the previous chapters. Alg-MA polymer solutions (2%, w/v) were
prepared with a DOM of 4.6%. The photo-initiator concentration of eosin Y was varied
from 0% (v/v) to 10% (v/v) and the TEOA concentration was held constant at 5% (v/v).
Next, the TEOA concentration was varied from 0% (v/v) to 10% (v/v) and the eosin Y
concentration was held constant at 0.5%. Gelation kinetics of the Alg-MA precursor
solutions with varying photo-initiator concentrations were assessed using an oscillatory
time sweep at 1 Hz and 10% radial strain. After 30 seconds of temperature equilibrium,
the solutions were exposed to visible green light, using a custom 9.84 cm diameter LED
array for 10 minutes. Shear storage moduli (G′) were calculated using analytical software
(TA Data Analysis).
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Figure 37: Changes in eosin Y concentration with constant TEOA concentration (mean ± standard
deviation)

The storage modulus of the hydrogel went from 29 Pa for 0% Eosin Y, which
resulted in a non-crosslinked hydrogel, to the highest storage modulus of 4495 Pa for 1%
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eosin Y. Statistical analysis was preformed using a one-way ANOVA with a Bonferroni
multiple comparison post-hoc test and an a=0.05.

Table 2: One-way ANVOA and Bonferroni multiple comparison post-hoc test results for the effect of
eosin Y concentration on crosslinking (* p≤0.05, **p≤0.01)

Groups
0% eosin Y vs. 0.1% eosin
Y
0% eosin Y vs. 0.5% eosin
Y

p-value

0.0022 **

0% eosin Y vs. 1% eosin Y

0.0003 **

0% eosin Y vs. 5% eosin Y
0% eosin Y vs. 10% eosin
Y
0.1% eosin Y vs. 0.5%
eosin Y
0.1% eosin Y vs. 1% eosin
Y
0.1% eosin Y vs. 5% eosin
Y

0.0057 **

0.16

>0.99
0.46
0.05*

Groups
0.1% eosin Y vs. 10%
eosin Y
0.5% eosin Y vs. 1% eosin
Y
0.5% eosin Y vs. 5% eosin
Y
0.5% eosin Y vs. 10%
eosin Y

p-value
0.41
>0.99
>0.99
0.0050 *

1% eosin Y vs. 5% eosin Y
>0.99
1% eosin Y vs. 10% eosin
Y
0.0007 **
5% eosin Y vs. 10% eosin
Y
0.013 *

>0.99

From Figure 37, it is clear that the highest storage modulus value was found using
the 1% eosin-Y concentration with a value of 4495 Pa. Looking at the Bonferroni
multiple comparison post-hoc test, the comparison of 1% eosin-Y and 0.5% eosin Y
showed a p-value of greater than one, indicating that there was no chance that the
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increase from 0.5% to 1.0% of eosin-Y had a significant effect on the storage modulus.
Therefore, in order to use the lowest concentration of the photo-initiator system for lower
cell cytotoxicity, the 0.5% eosin-Y concentration should be used for the highest storage
moduli.

2% Alg-MA
Changes in TEOA

Storage (G') Modulus (Pa)

10000

1000

100

10

1
0%

0.10%

0.50%

1%

5%

10%

Figure 38: Change in TEOA concentration with constant eosin Y concentration (mean ± standard
deviation)

The storage modulus of the hydrogel was tuned from 86 Pa for 0% TEOA, leaving
a non-crosslinked hydrogel, to 4027 Pa for 0.1% TEOA. Statistical analysis was
preformed using a one-way ANOVA with a Bonferroni multiple comparison post-hoc
test and an a=0.05.
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Table 3: One-way ANVOA and Bonferroni multiple comparison post-hoc test results for effect of
TEOA concentration on crosslinking (* p≤0.05, **p≤0.01)

Groups

p-value

0% TEOA vs. 0.1% TEOA

<0.0001 **

0% TEOA vs. 0.5% TEOA

<0.0001 **

0% TEOA vs. 1% TEOA

<0.0001 **

0% TEOA vs. 5% TEOA
0% TEOA vs. 10% TEOA
0.1% TEOA vs. 0.5%
TEOA

<0.0001 **
<0.0001 **

0.1% TEOA vs. 1% TEOA
0.1% TEOA vs. 5% TEOA

<0.0001 **
<0.0001 **

0.0003 **

Groups
0.1% TEOA vs. 10%
TEOA
0.5% TEOA vs. 1%
TEOA
0.5% TEOA vs. 5%
TEOA
0.5% TEOA vs. 10%
TEOA
1% TEOA vs. 5% TEOA
1% TEOA vs. 10%
TEOA
5% TEOA vs. 10%
TEOA

p-value
<0.0001 **
0.0037 **
0.0004 **
<0.0001 **
>0.99
0.0012 **
0.014 *

From Figure 38 it is clear that the highest storage modulus value was found using
the 0.1% TEOA concentration with a value of 4027 Pa. This was the lowest concentration
tested (other than 0%) that resulted in a non-crosslinked hydrogel. Therefore the 0.1%
TEOA concentration should be used for the highest storage moduli.
5.7. Conclusion
Using the methacrylated alginate (Alg-MA) as the base hydrogel for testing, Table
4 was created to summarize the results when varying the polymer concentration, polymer
DOM, and the photo-initiator concentrations. Photopolymerization allowed for higher
control over the final storage modulus compared to ionic crosslinking, because while
calcium chloride has rapid initial crosslinking, the extra ions cannot be removed once the
desired modulus is reached. Photopolymerization allows for a hydrogel to be crosslinked
in situ to a desired stiffness, and then with the removal of light, the storage modulus
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remains constant. The results from these studies prove that with just one form of
crosslinking (photopolymerization with visible green light), the hydrogel’s mechanical
properties can be easily tuned for a wide range of tissue engineering applications.
Table 4: Tunability of the storage modulus via green light crosslinking

Hydrogel
Variation

Variations

Starting
G’ value
(Pa)

Changes in
polymer
concentration
Changes in DOM

2% (w/v)
4% (w/v)
DOM = 1.2%
DOM = 4.6%
Eosin Y=0%
Eosin Y=0.1%
Eosin Y=0.5%
Eosin Y=1%
Eosin Y=5%
Eosin Y=10%
TEOA=0%
TEOA=0.1%
TEOA=0.5%
TEOA=1%
TEOA=5%
TEOA=10%

Changes in eosin
Y

Changes in TEOA

34.18
280.7

G’ value after
five minutes of
light exposure
(Pa)
535.85
2936.66

G’ value after
nine minutes
of light
exposure (Pa)
1592
5927.33

34.18
25.91
21.05
18.67
28.34
40.53
31.69
25.27
25.28
21.36
27.9
53.23
37.95
35.05

535.85
856.93
24.08
986.9
1732.5
1831.5
2253.66
113.7
29.76
2174.5
904.82
1077.25
865.93
453.3

1592
1737
28.88
1842.16
3224.33
3493.16
3142.16
366.76
43.77
3749.5
1571.69
1978.16
1737
1154.81

From Table 1 earlier, hydrogels for more general uses, such as drug delivery,
were selected and graphed below.
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Reported Hydrogel Storage Modulus (G’) Values (Pa)
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Figure 39: Previously studied hydrogel uses and storage modulus (Pa) values

These storage modulus values can be used as a guide to tune the mechanical properties of
the modified alginate hydrogels to a specific tissue engineering application. As seen in
Figure 40, the storage moduli can easily be tuned to fall within the reported values for use
in drug delivery, cardiovascular applications, and cartilage engineering. The added
benefit is eliminating the requirement for UV light in order to crosslink to protect any
encapsulated materials within the hydrogels. Although the mechanical properties were
varied, the higher storage moduli values in the megapascals are unattainable with the
modified alginate hydrogel systems.
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Tunability of the Storage Modulus (Pa) via Green Light Crosslinking
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Figure 40: Tunability of the storage modulus via green light crosslinking
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6.

CHAPTER 6: DRUG/GROWTH FACTOR DELIVERY
6.1. Introduction

In order to further control and reduce the release rate of growth factors from the
multi-crosslinking hydrogel, heparin was conjugated to the alginate backbone. Heparin
was discovered by an American physician, Dr. Jay McLean, in 1916 and has been widely
used as a pharmaceutical anticoagulant since the 1930s (Baldwin & Kiick, 2010).
Heparin is a glycosaminoglycan and contains abundant functional groups, including
hydroxyls, amines, sulfates, and carboxylic acids, allowing for simple graphing onto
polymers (Baldwin & Kiick, 2010). EDC/NHS coupling can be used to covalently
conjugate heparin onto the backbone of alginate (Chinen et al., 2003; Wissink et al.,
2001).
Glycosaminoglycans, more so in sulfate form, were identified to stabilize and
retain specific growth factors, such as bone morphogenetic proteins (BMPs), hepatocyte
growth factor (HGF), vascular endothelial growth factor (VEGF), and fibroblast growth
factor 2 (FGF-2) (Lau & Wang, 2013). The highly negative nature of heparin promotes
additional ionic interactions with biomolecules (Baldwin & Kiick, 2010). Growth factors
that bind to heparin can also be found on cell surfaces or extracellular matrices in native
tissue (Chinen et al., 2003).
Alginate and heparin conjugations have been previously used in the literature for
the controlled release of basic fibroblast growth factor (bFGF) and vascular endothelial
growth factor (VEGF) in hydrogels that were crosslinked with calcium chloride (Zuo et
al., 2015) (Du et al., 2014). In addition, bone morphogenetic protein 2 (BMP-2) has been
released from a UV crosslinked alginate-based hydrogel (Jeon et al., 2011). The
innovative approach in this study was that the hydrogels were crosslinked with visible
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green light in addition to specific groups containing β-cyclodextrin conjugations. In order
to mimic native extracellular matrix and control the release of encapsulated growth
factors, it is hypothesized that creating hydrogels containing heparin conjugated onto an
alginate backbone will reduce the rate of release of heparin binding growth factors. This
study focused on the delivery of vascular endothelial growth factor (VEGF) from
modified alginate injectable hydrogels in order to increase local angiogenesis.
6.1.1. Vascular Endothelial Growth Factor (VEGF)
Vascular endothelial growth factors are responsible for angiogenesis,
lymphangiogenesis, and vascular development within the body (K. Holmes et al., 2007).
Vascular endothelial growth factors are a sub-family of the platelet-derived growth
factors that include numerous members: VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGFE, and placenta growth factor (PGF), each with additional isoforms (Ruhrberg, 2008).
Vascular endothelial growth factor A (VEGF-A) is considered to be the most important
growth factor for the regulation of angiogenesis (Tan et al., 2012; A Zieris et al., 2011).
VEGF-A165 is the most active isoform of VEGF-A and it is the most abundant form in
humans (D. I. Holmes et al., 2005). For the following studies, human VEGF-A165 was
used. The heparin binding sites are located on the exons 7a and 7b on VEGF-A165, as
seen in Figure 41.
Heparin Binding Sites

VEGF-A165

Exons 1-5

Exon 7a

Exon 7b

Figure 41: Heparin binding sites on VEGF-A165
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Exon 8a

Exon 8b

6.2. Materials
Sodium alginate (PROTANAL® LF200 FTS, Mv = 67−142 kg/mol) was kindly
donated by FMC Biopolymer. Methacrylic anhydride, CaCl2, N-ethyl-N’(3dimethylaminopropyl) carbodiimide hydrochloric acid (EDC), N-hydroxysuccinimide
(NHS), Pluronic® F-108 [poly(ethylene glycol)-block-poly(propylene glycol)-blockpoly(ethylene glycol) (PEG-b-PPG-b-PEG), Mn = 15 kg/mol], Pluronic® F-127
[poly(ethylene oxide)-block-poly(propylene oxide)-block-poly(ethylene oxide) (PEO-bPPG-b-PEO), Mn = 13 kg/mol], triethanolamine, eosin Y, and 1-vinyl-2-pyrrolidinone
were purchased from Sigma Aldrich. β-cyclodextrin (β-CD), ρ-toluenesulfonyl chloride
(TosCl), acetonitrile, acetone, and ethylenediamine (EDA) were purchased from Acros
Organics. Sodium hydroxide (NaOH), hydrogen chloride (HCl), phosphate buffered
saline (PBS), the 2-morpholinoethanesulfonic acid (MES) buffer, human umbilical vein
endothelial cells (HUVECs), vascular cell baal medium, endothelial cell growth kit-BBE,
human VEGF DuoSet ELISA, vascular endothelial growth factor A 165 (VEGF-A165),
heparin sodium salt (Hep), and alpha-modified eagle medium (α-MEM, Hyclone) were
purchased from Thermo Fisher Scientific. Primary human MSCs, derived from bone
marrow, were purchased from Rooster Bio. Human MSC-screened fetal bovine serum
(FBS) was purchased from Atlanta Biologics. Penicillin, streptomycin, and trypsin
ethylenediaminetetraacetic acid (EDTA) were purchased from Corning Cellgro.
6.3. Chemical Modifications
For the synthesis of heparin conjugated to sodium alginate (Alg-Hep), heparin
sodium salt (Hep) (0.25 g) was slowly dissolved in 27.7ml of DI water. N-ethyl-N’(3dimethylaminopropyl) carbodiimide hydrochloric acid (EDC) (0.042 g) was added to the
Hep solution, followed by N-hydroxysuccinimide (NHS) (0.07 g). The reaction was
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allowed to stir at room temperature for 24 hours. A 20-molar excess of ethylenediamine
(EDA) (1.11 ml) was added and the reaction was stirred overnight in an ice bath. The
product (Hep-EDA) was frozen and lyophilized. Sodium alginate (Alg) (0.25 g) was
slowly dissolved in 145.28ml of DI water. N-ethyl-N’(3-dimethylaminopropyl)
carbodiimide hydrochloric acid (EDC) (0.22 g) was added to the Alg solution, followed
by N-hydroxysuccinimide (NHS) (0.13 g). The reaction was allowed to stir at room
temperature for 24 hours. The dried Hep-EDA was dissolved in 10ml of DI water, added
to the alginate solution and allowed to stir at room temperature for 24 hours. The AlgHep solution was purified via dialysis (MWCO = 6-8 kDa) against deionized water for
three to five days and lyophilized to yield a dry product.
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Figure 42: Chemical synthesis for Alg-Hep

6.3.1. Nuclear Magnetic Resonance (NMR)
To verify functional group conjugations onto the alginate backbone, dried polymer
products were dissolved in D2O (1% w/v). 1H-NMR was performed on a Bruker
AVANCE III 500 MHz high-field NMR spectrometer, for 16-32 scans at 20 Hz.
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Figure 44: NMR spectra for Alg-Hep

6.4. Polymer Blends
When attempting to conjugate the heparin group onto the previously modified AlgMA-β-CD, there was an undesired outcome. The heparin conjugation resulted in
significant reduction and occasionally the complete removal of the previously conjugated
acrylate groups. In theory, the conjugations should be possible, but due to unknown
chemical interactions between the materials, a large batch variation was found when
conjugating all three chemical modifications onto a single alginate backbone. Given the
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focus of the project was not to create a single polymer, but an injectable hydrogel, blends
of individually modified alginates were used in order to ensure the DOM for all
conjugations remained constant. The individually modified alginates consisted of AlgMA, Alg-β-CD, and Alg-Hep. The methacrylate conjugation (MA) allowed for the
hydrogel to be crosslinked via photopolymerization with visible green light. The βcyclodextrin conjugation (β-CD) allowed for the hydrogel to be combined with
Pluronics® for crosslinking via an increase in temperature. The cyclodextrins have been
proven to aid in drug delivery (Challa et al., 2005). Lastly, the conjugation of heparin
(Hep) enhanced growth factor retention within the hydrogel. All four blends used in the
following experiments had a base of 2% Alg-MA with mixtures of β-CD and Hep
conjugations. The hydrogel precursor solutions for the four tested blends were prepared
in PBS at the following concentrations and were mixed with photo-initiators (0.1% v/v
TEOA and 0.5% eosin Y) for all experiments, unless otherwise stated.
I.

2% Alg-MA

II.

2% Alg-MA blended with 2% Alg-Hep

III.

2% Alg-MA blended with 1% Alg-β-CD

IV.

2% Alg-MA blended with 2% Alg-Hep and 1% Alg-β-CD
6.5. Viscosity Testing and Curve Fitting

Viscosity tests were duplicated in order to ensure the heparin conjugation and the
blending of the polymers allowed for shear thinning polymer precursor solutions. Tests
were performed by increasing the shear rate from 0.01-s to 100-s at room temperature
(25°C) and body temperature (37°C). Curve fitting used the Power Law model to
determine mathematically if the material was shear thinning. This model does not
accurately describe the Newtonian plateau, therefore only values in the shear thinning
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range (10-100-s) were included in the equation. The Carreau-Yasuda model was used to
represent the entire shear thinning curve and predict viscosity values at higher shear rates
that were not included in the viscosity testing on the rheometer.
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Figure 45: Shear thinning behavior and curve fitting models for 2% Alg-MA at 25°C
2%Alg-MA 37ºC
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Figure 46: Shear thinning behavior and curve fitting models for 2% Alg-MA at 37°C
2%Alg-MA & 2% Alg-Hep 25ºC
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Figure 47: Shear thinning behavior and curve fitting models for 2% Alg-MA and 2%Alg-Hep at
25°C
2%Alg-MA & 2% Alg-Hep 37ºC
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Figure 48: Shear thinning behavior and curve fitting models for 2% Alg-MA and 2%Alg-Hep at
37°C
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2%Alg-MA & 1% Alg-B-CD 25ºC
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Figure 49: Shear thinning behavior and curve fitting models for 2% Alg-MA and 1%Alg-b-CD at
25°C
2%Alg-MA & 1% Alg-B-CD 37ºC

Viscosity (Pa.s)

100

10
Experimental
Values
Carreau-Yasuda
Power Law

1
0.1

1

10

100

1000

Shear Rate (1/s)

Figure 50: Shear thinning behavior and curve fitting models for 2% Alg-MA and 1%Alg-b-CD at
37°C
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2%Alg-MA & 2% Alg-Hep & 1% Alg-B-CD 25ºC
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Figure 51: Shear thinning behavior and curve fitting models for 2% Alg-MA, 2%Alg-Hep and
1%Alg-b-CD at 25°C
2%Alg-MA & 2% Alg-Hep & 1% Alg-B-CD 37ºC
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Figure 52: Shear thinning behavior and curve fitting models for 2% Alg-MA, 2%Alg-Hep and
1%Alg-b-CD at 37°C
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From the above viscosity graphs, it can be seen that all four blends of hydrogel
precursor solution were shear thinning at both room temperature (25°C) and body
temperature (37°C). The n values for the curve fitting models were tabulated at both 25°C
and 37°C.
Table 5: Tabulated ‘n’ values for viscosity curve fitting model equations

Hydrogel Precursor Solution
2% Alg-MA
2% Alg-MA and 2%Alg-Hep
2% Alg-MA and 1%Alg-b-CD
2% Alg-MA, 2%Alg-Hep and 1%Alg-b-CD

Temp

Power
Law
n

25℃
37℃
25℃
37℃
25℃
37℃
25℃
37℃

0.67
0.72
0.61
0.64
0.56
0.61
0.54
0.57

CarreauYasuda
Model
n
0.88
0.39
0.81
0.83
0.73
0.70
0.63
0.65

All n values for both the Power Law model and the Carreau-Yasuda model were less than
one, indicating that all four materials were mathematically verified to be shear thinning.
In addition, apart from the 2% Alg-MA Carreau-Yasuda model value of 0.39, which was
an outlier in the data, as the blend progressed from first group to last, shear thinning
increased. This could be explained by the polymer chains within the precursor solutions
becoming aligned with the direction of flow and the additional polymer chains in the
higher concentration blends causing quicker alignment.
6.6. Qualitative Injection Testing
In order to ensure that the polymer blends were injectable and able to crosslink in
situ, a qualitative test on a chicken purchased from a local grocery store was performed.
Hydrogel precursors were loaded into 1 mL syringes and injected under raw chicken skin,
subcutaneously, with an 18 G needle. Qualitatively, although more pressure was needed
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on the syringe compared with water, all four polymer blends were effortlessly injectable
using a single hand.

Figure 53: Injection of hydrogel blends under raw chicken skin using 18 G needle

Visible green light was applied approximately 10 cm from the skin surface for 10
minutes, confirming that the hydrogels could be crosslinked after injection. Since chicken
skin is thin, the green light was able to penetrate through, but ideally in a surgical setting
arthroscopic light sources will be used.

Figure 54: Green light crosslinking of injected hydrogel
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Crosslinked hydrogels were carefully excised from the chicken skin. All four hydrogel
blends were successfully injected and crosslinked to form hydrogels that were solid
enough to remove in a single piece.

Figure 55: Removal of injected and crosslinked hydrogel

The results of this qualitative experiment confirmed that the hydrogel precursor solutions
were sufficiently shear thinning, injectable and could be crosslinked in situ in a desired
location using a syringe and an 18 G needle.
6.7. Green Light vs Calcium Chloride Crosslinking
Gelation kinetics for all four polymer blends were tested with both ionic and
photopolymerization crosslinking to ensure the conjugation of heparin did not interfere
with crosslinking. In addition, these polymer blends are new biomaterials, so the base
mechanical properties were measured to allow for accurate future use. Precursor solutions
were assessed using an oscillatory time sweep at 1 Hz and 10% radial strain. After 30
seconds of temperature equilibrium, the solutions were exposed to visible green light for
10 minutes using a custom LED array. Shear storage moduli (G′) were calculated using
analytical software (TA Data Analysis).
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Figure 56: Green light vs. calcium chloride crosslinking for 2% Alg-MA (mean ± standard deviation)
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Figure 57: Green light vs. calcium chloride crosslinking for 2% Alg-MA and 2% Alg-Hep (mean ±
standard deviation)
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Figure 58: Green light vs. calcium chloride crosslinking for 2% Alg-MA and 1% Alg-b-CD (mean ±
standard deviation)
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Figure 59: Green light vs. calcium chloride crosslinking for 2% Alg-MA, 2% Alg-Hep and 1% Alg-bCD (mean ± standard deviation)
Table 6: Tunability of the storage modulus for hydrogel blends

Hydrogel
Variation

Crosslinking
Method

Starting G’
(Pa)

G’ after 10 minutes of
light exposure (Pa)

2% Alg-MA

Green Light
0.1 M CaCl2

16.64
20.48

2924.33
10850.66
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2% Alg-MA and
2% Alg-Hep
2% Alg-MA and
1% Alg-b-CD
2% Alg-MA, 2%
Alg-Hep and 1%
Alg-b-CD

Green Light

81.32

1505.66

0.1 M CaCl2
Green Light
0.1 M CaCl2
Green Light

105.88
61.10
75.92
129.13

6599.33
2664
10655.66
2188.66

0.1 M CaCl2

234.33

10036.66
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Figure 60: Tunability of the storage modulus for hydrogel blends

As mentioned in previous sections, the storage modulus values in Figure 39 can be
used as a guide to tune the mechanical properties of hydrogel blends to a specific tissue
engineering application. As seen in Figure 60, the storage moduli of the blends were
distinctive from the storage moduli of the Alg-MA studied earlier. Further, the blends can
still be tuned with the use of ionic and photopolymerization crosslinking for several
tissue engineering applications. Specifically, the hydrogel blends fall within the
previously reported ranges for drug delivery applications, which was the focus of these
experiments.
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6.8. Cell Adhesion Assay
Although it is well known that unmodified alginate does not promote cell adhesion,
it was hypothesized that the addition of the heparin conjugation could enhance cell
adhesion to the hydrogel, due to the negativity of heparin. In order to test this hypothesis
two cell lines were used, human mesenchymal stem cells (MSCs) and human umbilical
vein endothelial cells (HUVECs).
Hydrogel precursor solutions (1 mL) were added into a 12 well plate and
crosslinked for 10 minutes via visible green light. Three wells were prepared for each
hydrogel group. Images of crosslinked hydrogels were taken before the addition of cells.
All imaging for this study was performed with an Olympus BX53 microscope and the
CellSens software.

A)

B)

250 µm

250 µm

C)

D)

250 µm

250 µm
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Figure 61: Green light crosslinked hydrogels before addition of cells A) 2% Alg-MA B) 2% Alg-Ma
and 2% Alg-Hep C) 2% Alg-Ma and 1% Alg-β-CD D) 2% Alg-Ma, 2% Alg-Hep and 1% Alg-β-CD

6.8.1. Human Mesenchymal Stem Cells
Human Mesenchymal Stem Cells (MSCs) were seeded in T75 tissue culture flasks
at a density of 0.3x106 cells per flask, in 10 mL of standard MSC growth media (alpha
minimum essential medium supplemented with 10% FBS, 100 U mL-1 penicillin, and
100 mg mL-1 streptomycin), and cultured at 37°C with 5% CO2 until 80% confluent.
MSCs were expanded to create a stock solution (passages 4-6).
Cells were seeded onto the hydrogels at a density of 0.2x106/well and covered in 4
mL of cell media. Controls were seeded at the same density directly onto the treated
tissue culture plastic. Images of seeded hydrogels were taken directly after addition (hour
0). Seeded hydrogels were incubated at 37°C and 5% CO2 for 48 hours. After 48 hours,
the media was aspirated and replaced with fresh media and imaged (hour 48).
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Figure 62: Human mesenchymal stem cells control seeded onto treated tissue culture plastic after
initial seeding (0 hours) and after 48 hours
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Figure 63: Human mesenchymal stem cells seeded onto 2% Alg-MA after initial seeding (0 hours)
and after 48 hours
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Figure 64: Human mesenchymal stem cells seeded onto 2% Alg-MA and 2% Alg-Hep after initial
seeding (0 hours) and after 48 hours
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Figure 65: Human mesenchymal stem cells seeded onto 2% Alg-MA and 1% Alg-b-CD after initial
seeding (0 hours) and after 48 hours
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Figure 66: Human mesenchymal stem cells seeded onto 2% Alg-MA, 2% Alg-Hep and 1% Alg-b-CD
after initial seeding (0 hours) and after 48 hours

6.8.2. Human umbilical vein endothelial cells
Human umbilical vein endothelial cells (HUVECs) were seeded in T75 tissue
culture flasks at a density of 0.3x106 cells per flask, in 10 mL of standard HUVECS
growth media (vascular cell basal medium supplemented with 0.2% bovine brain extract
(BBE), 5 ng/ml rh EGF, 10nM L-glutamine, 0.75 Units/ml heparin sulfate, 1 µg/ml
hydrocortisone hemisuccinate, 2% fetal bovine serum (FBS), and 50 µg/ml ascorbic
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acid), and cultured at 37°C with 5% CO2 until 80% confluent. HUVECS were expanded
to create a stock solution (passages 2-4).
Cells were seeded onto the hydrogels at a density of 0.2x106/well and covered in 4
mL of cell media. Controls were seeded at the same density directly onto the treated
tissue culture plastic. Images of seeded hydrogels were taken directly after the addition of
cells (hour 0). Seeded hydrogels were incubated at 37 °C and 5% CO2 for 48 hours. After
48 hours, the media was aspirated and replaced with fresh media and imaged (hour 48).
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Figure 67: Human umbilical vein endothelial cells control seeded onto treated tissue culture plastic
after initial seeding (0 hours) and after 48 hours
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Figure 68: Human umbilical vein endothelial cells seeded onto 2% Alg-MA and 2% Alg-Hep after
initial seeding (0 hours) and after 48 hours
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Figure 69: Human umbilical vein endothelial cells seeded onto 2% Alg-MA and 2% Alg-Hep after
initial seeding (0 hours) and after 48 hours
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Figure 70: Human umbilical vein endothelial cells seeded onto 2% Alg-MA and 1% Alg-b-CD after
initial seeding (0 hours) and after 48 hours
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Figure 71: Human umbilical vein endothelial cells seeded onto 2% Alg-MA, 2% Alg-Hep and 1%
Alg-b-CD after initial seeding (0 hours) and after 48 hours

6.8.3. Cell Adhesion Conclusion
Qualitative analysis of the hydrogels clearly showed the cells remained round and
unattached to the surface of all four hydrogel groups, as compared to the attached cells
seen in the controls for the MSCs in Figure 62 and HUVECs in Figure 67. These results
confirm that all four hydrogel blends do not contain any cell adhesion locations and if
cell adhesion is needed for future use, additional chemical modifications will be required.
6.9. Swelling
The swelling of a hydrogel can relate to the release rates of encapsulated drugs. In
order to examine the swelling effect of the hydrogels, two assays were performed:
swelling from a dry start and swelling from hydrogel formation. The swelling observed
directly after hydrogel crosslinking will be referred to as physiological swelling, as it
closely resembles the swelling of the material when injected into a body.
6.9.1. Green Light Crosslinked Swelling from Dry Plug
Hydrogel precursor solutions of 2% Alg-MA, 2% Alg-MA and 2% Alg-Hep, 2%
Alg-MA and 1% Alg-b-CD, and 2% Alg-MA, 2% Alg-Hep and 1% Alg-b-CD and
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photo-initiators (5% v/v TEOA and 0.5% eosin Y) were prepared in PBS. Hydrogel
precursor solutions were loaded into 1 mL syringes and crosslinked for 10 minutes via
visible green light. The hydrogel plugs were removed, cut into 200 µL sections, frozen,
and lyophilized until dry. Hydrogel plugs were placed in 24 well plates and covered in 2
ml of PBS. Plugs were allowed to incubate at 37°C and were then removed and weighed
after 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 12, 24 and 48 hours.
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Figure 72: Swelling of hydrogel blends from a dry start over 48 hours (mean ± standard deviation)

From the dry to swollen state, Figure 72 demonstrated that the majority of swelling
occurred within the first 30 minutes and only increased 11% more on average over the
next 11.5 hours to the maximum swell at the 12 hours mark.
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Figure 73: Maximum swelling of hydrogel blends from a dry start (mean ± standard deviation)

Each of the four polymer groups reached maximum swell from a dry start after 12 hours.
The 2% Alg-MA, 2% Alg-Hep and 1% Alg-b-CD hydrogel plug increased the most of
the four tested blends (1137%) from the original dry weight. The second highest was the
2% Alg-MA and 1% Alg-Hep group with a 1083% increase. The 2% Alg-MA hydrogel
plug increased 1006% from the original dry weight. Finally, the lowest swelling was
observed in the 2% Alg-MA and 1% Alg-b-CD hydrogel plug with an 865% increase.
Significant swelling was expected, as it is a material property of a hydrogel to retain
aqueous solutions. Statistical analysis was preformed using a one-way ANOVA with a
Bonferroni multiple comparison post-hoc test and an a=0.05.

Table 7: One-way ANVOA and Bonferroni multiple comparison post-hoc test results for maximum
swelling from a dry start for blended hydrogels (* p≤0.05, **p≤0.01)

Comparisons
2% Alg-MA vs. 2%Alg-MA and 2% Alg-Hep
2% Alg-MA vs. 2% Alg-MA and 1% Alg-b-CD
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p-value
0.05 *
0.0014 **

2% Alg-MA vs. 2%Alg-MA, 2% Alg-Hep and 1% Alg-bCD
2% Alg-MA and 2% Alg-Hep vs. 2% Alg-MA and 1% Algb-CD
2% Alg-MA and 2% Alg-Hep vs. 2% Alg-MA, 2% Alg-Hep
and 1% Alg-b-CD
2% Alg-MA and 1% Alg-b-CD vs. 2% Alg-MA, 2% AlgHep and 1% Alg-b-CD

0.0022 **
<0.0001 **
0.24
<0.0001 **

Significant differences were found in all but one group. The comparison of blends
that both contained heparin conjugations, 2% Alg-MA and 2% Alg-Hep vs. 2%Alg-MA,
2% Alg-Hep and 1% Alg-b-CD, showed no difference in swelling. The results imply that
swelling of the hydrogel significantly increased when blended with conjugated heparin.
6.9.2. Green Light Crosslinked Physiological Swelling
Hydrogel precursor solutions 2% Alg-MA, 2% Alg-MA and 2% Alg-Hep, 2% AlgMA and 1% Alg-b-CD, and 2%Alg-MA, 2% Alg-Hep and 1% Alg-b-CD and photoinitiators (5% v/v TEOA and 0.5% eosin Y) were prepared in PBS. Hydrogel precursor
solutions were loaded into 1 mL syringes and crosslinked for 10 minutes via visible green
light. The hydrogel plugs were then removed, and cut into 200 µL sections. Hydrogel
plugs were placed directly into 24 well plates and covered in 2 mL of PBS. Plugs were
allowed to incubate at 37°C and were then removed to weigh after 0.5, 1, 2, 3, 4, 5, 6, 7,
8, 12, 24 and 48 hours.
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Figure 74: Physiological swelling of hydrogel blends over 48 hours (mean ± standard deviation)

Figure 74 demonstrated that the maximum swelling for all four hydrogel blends
occurred after 24 hours.
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Figure 75: Maximum physiological swelling of hydrogel blends (mean ± standard deviation)

Each of the four polymer groups reached maximum swell from a dry start after 24 hours.
The 2% Alg-MA, 2% Alg-Hep and 1% Alg-b-CD hydrogel plug increased the most of
the four tested blends with a 107% increase from the original dry weight. The second
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highest was the 2% Alg-MA and 1% Alg-Hep group with a 105% increase. The 2% AlgMA hydrogel plug increased 50% from the original dry weight. Finally, the lowest
amount of swelling was observed in the 2% Alg-MA and 1% Alg-b-CD hydrogel plug
with a 29% increase. Although some swelling was expected, the 100% increase was not,
as the hydrogel started in an aqueous solution prior to crosslinking. The highly negative
nature of the conjugated heparin may have increased the retention of water within the
hydrogel. Statistical analysis was preformed using a one-way ANOVA with a Bonferroni
multiple comparison post-hoc test and an a=0.05.
Table 8: One-way ANVOA and Bonferroni multiple comparison post-hoc test results for
physiological maximum swelling for blended hydrogels (* p≤0.05, **p≤0.01)

Comparisons
2% Alg-MA vs. 2%Alg-MA and 2% Alg-Hep
2% Alg-MA vs. 2% Alg-MA and 1% Alg-b-CD
2% Alg-MA vs. 2%Alg-MA, 2% Alg-Hep and 1%
Alg-b-CD
2%Alg-MA and 2% Alg-Hep vs. 2% Alg-MA and
1% Alg-b-CD
2%Alg-MA and 2% Alg-Hep vs. 2%Alg-MA, 2%
Alg-Hep and 1% Alg-b-CD
2% Alg-MA and 1% Alg-b-CD vs. 2%Alg-MA, 2%
Alg-Hep and 1% Alg-b-CD

p-value
0.0001 **
0.045 *
<0.0001 **
<0.0001**
>0.99
<0.0001 **

Similar to the swelling from a dry hydrogel, significant differences were found in all but
one group. The comparison of blends that both contained heparin conjugations, 2%AlgMA and 2% Alg-Hep vs. 2%Alg-MA, 2% Alg-Hep and 1% Alg-b-CD, showed no
difference in swelling.
6.10. Growth Factor Release Study
Heparin was added to hydrogel scaffolds in order to increase growth factor
retention. The conjugation of heparin should also prevent a burst release of the growth
factor (Lau & Wang, 2013; Sakiyama-Elbert & Hubbell, 2000). A drug release study was
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used to determine if the conjugation of heparin had a significant impact on the release
rate of VEGF from the greenlight crosslinked hydrogels.
6.10.1. Growth Factor Release Methods and Results
Hydrogel precursor solutions 2% Alg-MA, 2%Alg-MA and 2% Alg-Hep, 2% AlgMA and 1% Alg-b-CD, and 2%Alg-MA, 2% Alg-Hep and 1% Alg-b-CD and photoinitiators (5% v/v TEOA and 0.5% eosin Y) were fabricated in sterile PBS. VEGF-A165
was added to the hydrogel precursors at a concentration of 1 µg/mL and the precursor
solutions were allowed to equilibrate overnight at 37°C in complete darkness. After
equilibration, the precursor solutions were loaded into 1 mL syringes and crosslinked
with visible green light for 10 minutes. Hydrogels were then cut into 0.2 mL sections and
were added to 12 well plates filled with 2 mL of sterile PBS per well. At each timepoint
over 10 days, 100 µL of solution was removed from each well and replaced with 100 µL
of sterile PBS. After completion of the 10-day study, an ELISA was run to determine the
release rate of VEGF from each hydrogel group. Samples were run in triplicate and
averages were reported.
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Figure 76: VEGF release over the first 24 hours (mean ± standard deviation, * p≤0.05, **p≤0.01)

As discussed previously, the hydrogel blends all contained 2% Alg-MA as the base
material to allow for green light crosslinking. From Figure 76, it is clear that the 2% Alg98

MA released the most VEGF (18%) in the first 24 hours, and the lowest release (6%) was
seen by blending conjugated heparin and β-cyclodextrin (2% Alg-MA, 2% Alg-Hep and
1% Alg-b-CD).
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Figure 77: VEGF release over 10 days (mean ± standard deviation, * p≤0.05, **p≤0.01)

From Figure 77, it is clear that the 2% Alg-MA released the most VEGF (30%) over 10
days and the lowest release (11%) was seen by blending conjugated heparin and βcyclodextrin (2% Alg-MA, 2% Alg-Hep and 1% Alg-b-CD). Statistical analysis was
preformed using a T-test to compare each addition of Alg-Hep, Alg-b-CD, and both AlgHep and Alg-b-CD to the base Alg-MA hydrogel at an a=0.05 for each timepoint.
At each timepoint there was significance found between the base group (Alg-MA)
and the addition of Alg-Hep, Alg-b-CD, and both Alg-Hep and Alg-b-CD. This result
indicates that the conjugation of heparin and β-cyclodextrin effectively lowered the
release rate of VEGF from a visible green light crosslinked hydrogel. In addition, the
conjugation of β-cyclodextrin was superior to heparin for delaying the release of VEGF
from the hydrogel.
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6.11. Polymer Blend Cell Viability Testing
To quantify the possible cytotoxicity associated with the photo-initiator used in the
modified hydrogels, an MTT Assay was used to measure cell viability as a function of
photo-initiator concentration. The MTT assay is defined as “the capacity of mitochondrial
enzymes of viable cells to transform the MTT tetrazolium salt into MTT formazan or on
the endogenous hexosaminidase activity of viable cells” (Gerlier et al., 1986). A higher
concentration of MTT formazan is associated with higher cell viability. The control
groups for the MTT test were unaltered cells growing under normal conditions in a cell
treated tissue culture plastic well. The control groups were used to set the viability of
cells at 100% for comparison to other groups. For the following tests, two cell lines were
used, human mesenchymal stem cells (MSCs) and human umbilical vein endothelial cells
(HUVECs).
6.11.1. Cell Culture and 24 Well Seeding
Human mesenchymal stem cells (MSCs) were seeded in T75 tissue culture flasks at
a density of 0.3x106 cells per flask, in 10 mL of standard MSC growth media (alpha
minimum essential medium supplemented with 10% FBS, 100 U mL-1 penicillin, and
100 mg mL-1 streptomycin), and cultured at 37°C with 5% CO2 until 80% confluent.
MSCs were expanded to create a stock solution (passages 4-6). Human umbilical vein
endothelial cells (HUVECs) were seeded in T75 tissue culture flasks at a density of
0.3x106 cells per flask, in 10 mL of standard HUVECS growth media (vascular cell basal
medium supplemented with 0.2% bovine brain extract (BBE), 5 ng/ml rh EGF, 10nM Lglutamine, 0.75 Units/ml heparin sulfate, 1 µg/ml hydrocortisone hemisuccinate, 2% fetal
bovine serum (FBS), and 50 µg/ml ascorbic acid), and cultured at 37°C with 5% CO2
until 80% confluent. HUVECS were expanded to create a stock solution (passages 2-4).
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Cells were seeded on a 24 well plate at a density of 100,000 cells/well for both MSCs and
HUVECs and allowed to adhere for 24 hours. Each 24 well plate contained controls of
normal cell growth and negative cytotoxic control of 10% sodium dodecyl sulfate (SDS)
in triplicate.
6.11.2. Photo-Initiator and Polymer Blend Additions
After 24 hours, media was aspirated off and replaced with fresh media. A range of
Stock eosin Y was created from 0.1% to 10.0% in cell media and added to wells in
triplicate. A range of stock TEOA was created from 0.1% to 10.0% in cell media and
added to wells in triplicate. Hydrogel precursor solutions of 2% Alg-MA, 2%Alg-MA
and 2% Alg-Hep, 2% Alg-MA and 1% Alg-b-CD, and %Alg-MA, 2% Alg-Hep and 1%
Alg-b-CD, and photo-initiators (5% v/v TEOA and 0.5% eosin Y) for the higher photoconcentrations and the lower concentrations (0.1% v/v TEOA and 0.5% Eosin Y) were
prepared in PBS. The hydrogel precursor solutions (0.2 mL) were added to culture inserts
(8 µm pore size, BD Falcon, USA) in triplicate and exposed to green light (510 nm) for
10 minutes. Inserts were added to the 24 well plates. All 24 well plates were incubated at
37°C and 5% CO2 for 24 hours.
6.11.3. MTT Assay
After 24 hours, media was aspirated off and replaced with fresh media (100 µL).
10% MTT solution (10 µl, 5 mg/mL) was added to each well and incubated at 37°C and
5% CO2 for four hours. MTT solution was carefully aspirated from each well. Crystals
from the MTT were dissolved in 100 µL dimethyl sulfoxide and carefully agitated for
one minute. 50 µL of each solution was transferred into a 96-well plate and absorbance
was measured at 540 nm using a microplate reader (H1 Synergy, BioTek) to calculate
cell viability based on the controls.
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Figure 78: MTT results for varying eosin Y concentrations (mean ± standard deviation)

As the concentration of eosin Y increased, the viability of the cells decreased. The
results also indicated that HUVECs may be more sensitive to eosin Y than MSCs given
the lower viability values. When possible, lower concentrations of Eosin Y should be
used for crosslinking to increase cell viability, confirming that the eosin-Y photo-initiator
system has shown cytotoxic effects (Bahney, 2011).
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Figure 79: MTT results for varying TEOA concentrations (mean ± standard deviation)

As the concentration of TEOA increased, the viability of the cells decreased. One
contradiction to this result was that the MSCs had higher viability than the control values
at 0.10% TEOA concentration. However, the HUVEC results from the same
concentration also seemed to be outliers. The results also indicated that HUVECs may be
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more sensitive to TEOA than MSCs. As expected from the results from the eosin Y trials,
in order to enhance cell viability, lower concentrations of TEOA should be used for
crosslinking.
Change in Photo-initator Concentraion
120

**

Viability Percent

100
80

**

**

*

60

Low
High

40
20
0
Control

2% Alg-MA

2% Alg-MA
+ 2% Alg-Hep

2% Alg-MA
+ 1% Alg-BCD

2% Alg-MA
+ 2% Alg-Hep
+ 1% Alg-BCD

Figure 80: MTT results for MSCs with low vs. high photo-initiator concentrations (mean ± standard
deviation, * p≤0.05, **p≤0.01)

The MTT data proved that decreasing the concentration from 5% v/v TEOA and
0.5% eosin Y down to 0.1% v/v TEOA and 0.5% eosin Y significantly increased the
viability of MSCs. During the crosslinking optimization studies performed previously,
lower concentrations of the photo-initiators also resulted in higher storage modulus
values. In order to increase the biocompatibility of the hydrogel, lower concentrations of
photo-initiators should be used.
6.12. Conclusion
In the previously described studies, four polymer blends containing Alg-MA, AlgHep and Alg-b-CD were characterized. The mechanical characterization proved that the
hydrogel precursor solutions were shear-thinning and could be ionically crosslinked with
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calcium chloride or visible green light. The conjugation of heparin was found to
significantly increase the swelling of the hydrogel. The swelling has an effect on the
release rates of encapsulated drugs, so it is important to understand that the heparin
conjugation increased swelling for both dry and injected hydrogels crosslinked with
visible green light. The heparin conjugation also influenced the VEGF release profile
from a green light crosslinked hydrogel, reducing the rate of release. The delayed release
of the VEGF is beneficial to promoting vascularization both within the 3D structure of
the hydrogel as well as in the surrounding tissues. Lastly, cytotoxicity testing of the
photo-initiator components was performed on human umbilical vein endothelial cells and
mesenchymal stem cells. Lowering the concentrations of the photo-initiator system in the
hydrogel blends was found to increase MSC cell viability, therefore increasing
biocompatibility.
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7.

CHAPTER 7: CONCLUSIONS AND FUTURE WORK
7.1. Conclusions

A non-synthetic material, sodium alginate, was successfully chemically modified
for use in a novel hydrogel for tissue engineering applications, including cell and drug
delivery. Sodium alginate was chosen for the backbone of the polymers used in this
project in order to combat issues to do with synthetic polymers, such as toxic degradation
byproducts. In additional, sodium alginate has a naturally shear thinning property, which
is ideal for injectable hydrogels and in situ crosslinking. The less invasive surgeries
required for injectable hydrogels also reduce surgical and recovery times.
Chemical modifications to the sodium alginate increased mechanical properties and
maintained the shear thinning behavior. The chemical modifications allowed for a multistimuli responsive hydrogel (Alg-MA-β-CD:Pluronic®) that can be crosslinked with: 1)
temperature increase, 2) green light exposure, and 3) the addition of calcium chloride. All
three crosslinking techniques were non-UV dependent to ensured cells and drugs were
encapsulated without significant damage. By varying temperature (25-37°C), polymer
concentration (2 and 4%, w/v), and Pluronic® copolymer selection (F-108 or F-127), the
shear stiffness for the stimuli-responsive Alg-MA-β-CD:Pluronic® hydrogels was
controlled between <1 and >34 kPa; well within the range required to mimick the
material properties of soft tissues.
The multi-stimuli responsive hydrogel (Alg-MA-β-CD:Pluronic®) was used to
encapsulate MSCs and support MSC viability for over 48 hours after exposure to
temperature, visible green light, and ionic crosslinking techniques in standard culture
conditions. Viable MSCs were encapsulated successfully in 2% Alg-MA-β-CD
microspheres with the use of a fabricated microfluidic device and were crosslinked via
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visible green light and calcium chloride. As discussed earlier, the encapsulated cells can
be used to release proteins and growth factors into the surrounding tissues to aid in tissue
repair or regeneration. These results indicate that the cells can be delivered in situ, in
either a bulk hydrogel, or within microspheres to enhance cell viability and retention at a
specific location.
By varying the degree of modification during synthesis or by altering the
concentrations of the polymers or additives, the mechanical properties of the hydrogel
can be optimized for a specific use in tissue engineering or cell/drug delivery.
Considering the Alg-MA hydrogel and the use of visible light crosslinking, the
mechanical properties were tuned from 20 Pa to 6000 Pa. That range of storage moduli
fits within reported requirements for cardiovascular applications, drug delivery, and
cartilage engineering, among numerous other applications.
The conjugation of heparin onto the backbone of alginate allowed for hydrogel
blends to be created with varying swelling, storage moduli, and VEGF release profiles
that had minimal toxicity effects on the surrounding cells. With additional testing,
heparin conjugation could prove to significantly increase local vascularization
surrounding the hydrogel, in addition to promoting vascularization within the 3D
structure of the hydrogel.
With the choice of four conjugated alginates (Alg-MA, Alg-β-CD, Alg-MA-β-CD,
and Alg-Hep) with up to three different crosslinking techniques, the mechanical
properties of the hydrogel can be optimized for use in tissue engineering. Apart from
varying mechanical properties, the hydrogel blends support stem cell viability and can be
used for controlled drug/growth factor release. Due to the shear thinning properties, the
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blends can be injected into a specified location and crosslinked in situ without the need
for additional supporting materials to generate or repair biological tissues.
7.2. Future Work
7.2.1. Angiogenesis Testing
In order to test the angiogenic or anti-angiogenic effects of a biomaterial in vivo, a
chicken embryo chorioallantoic membrane (CAM) assay can be used (Kue et al., 2015,
Valdes, 2002 #242; Li et al., 2017). There are two techniques for a CAM assay: in ovo (in
eggshell) or ex ovo (out of eggshell). The in ovo method involved cutting a window in the
egg shell but allowed for limited access to the CAM. The ex ovo method involved
cracking eggs into a secondary container, such as a petri dish, which allowed for
extensive access to the CAM, but reduced viability (Dohle et al., 2009; West et al., 2001).

Figure 81: in ovo (left) and ex ovo (right) CAM assay examples

This model also follows the three ‘Rs’ of the Principles of Humane Experimental
Techniques: reduction, replacement, and refinement (Russell et al., 1959). The CAM
assay is considered to be a middle ground between in vitro cell testing and in vivo animal
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testing. The CAM assay is a preclinical model used as a less expensive alternative to in
vivo animal studies, and is therefore a replacement to using a mouse model (Lokman et
al., 2012). According to the Institutional Animal Care and Use Committee (IACUC),
chicken embryos feel zero pain before embryonic day 14, allowing this assay to be run
without any ethical restrictions or need for protocol approval. This follows the refinement
technique in that it minimizes and removes any pain caused to an animal. Finally, the
assay also allows for multiple samples to be placed on each CAM, reducing the total
number of animals used. One major downside of this assay is the large number of eggs
needed in order to obtain data. It is also important to note that the results of this animal
study are non-mammalian, though studies have shown that it still provides similar results
to those in mammalian models (Kue et al., 2015). Preliminary CAM studies using the
modified hydrogels can be seen in Appendix 9.1.
7.2.2. Material Use as Bio-Ink in 3D Printing
Patient specific implants are on the rise in the field of tissue engineering, due to the
ability to use magnetic resonance imagery (MRI) or computed tomography (CT) files for
3D printing (Hinton et al., 2015). Bio-inks show potential for use in creating not only
complex tissues within the body, but also providing a secondary function as a drug,
protein, or cell delivery system. The chemical modification of the alginate backbone
allows for bio-inks to be tailored for a specific crosslinking method or medical
application, while the 3D printing methods allow for patient specific shapes to be
fabricated. As previously mentioned, methacrylate conjugation (MA) allows for a bio-ink
to be crosslinked into a hydrogel during 3D printing via photopolymerization. The βcyclodextrin conjugation (β-CD) allows for crosslinking to occur during printing via an
increase in temperature. The cyclodextrins and/or conjugation of heparin (Hep) can affect
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drug/growth factor release profiles once an object is printed and implanted into the body.
Preliminary studies using the modified hydrogels can be seen in Appendix 9.2.
7.2.3. Arginylglycylaspartic acid (RGD) Conjugation
Although alginate has often been used as a drug and cell delivery method, it has
limited adhesion and proliferation of mammalian cells, due to the lack of receptors (des
Rieux et al., 2014). Thus, the addition of bioactive motifs are required, such as RGD to
allow for cell binding sites (Lau & Wang, 2013). The addition of RGD will allow for the
encapsulated cells to proliferate within the hydrogel, reducing the number of cells needed
for the original encapsulation.
7.2.3.1. Chemical Reactions for RGD Conjugation onto Alginate
Alg (0.5 g) was dissolved in a 0.1 M MES buffer (pH 5.6, 25 mL) to which EDC
(0.33 g) and NHS (0.2 g) were added. After mixing for 30 minutes at room temperature,
RGD (5 mg) was added and mixed vigorously at room temperature for 24 hours. The
Alg-RGD solution was purified via dialysis (MWCO = 6-8 kDa) against deionized water
for three to five days and lyophilized to yield a dry product.
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9.

APPENDICES

9.1. Angiogenic Testing (CAM Assay)
9.1.1. CAM Assay: Small Hydrogels
Based on the previous assay development trials, the protocol with the highest
viability was used. Eggs were allowed to sit at room temperature for a longer period of
time (24 hours), rather than the six hours suggested in the literature. Upon arrival, the
eggs were washed, marked with “X” and “O”, and allowed to sit at room temperature for
24 hours. Eggs were incubated for the first three days, turning 180 degrees three to five
times a day using the “X” and “O” markings as guides.

Figure 83: Chicken eggs upon arrival, resting at room temperature for 24 hours, and incubating for
three days

On day three, all 24 eggs were cracked into 89 mm by 89 mm square weigh boats
ventilated with a 21-gauge needled and covered with a 100 mm by 100 mm square sterile
petri dish. Eggs were allowed to sit undisturbed until embryonic day 10 with humidity
checked daily and DI water added to the incubator as needed.
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Figure 84: Cracking egg shell, lowering egg close to weigh boat, and releasing egg contents into weigh
boat

Hydrogel precursor solutions, 2% Alg-MA, 2%Alg-MA and 2% Alg-Hep, with
photo-initiators (5% v/v TEOA and 0.5% eosin Y) were prepared in PBS with and
without the addition of 1.0 µg/ml of VEGF. Hydrogel precursors (1 mL) were added into
a 12 well plate and crosslinked in visible green (510 nm) light for 10 minutes. Biopsy
punches (6 mm) were used to punch out hydrogel samples of 6 mm by 3 mm.

Figure 85: Example of 6mm by 3mm hydrogel disk

Hydrogels were added to the CAMs of the three viable eggs on embryonic day 10
according to the application maps (Figure 86) and imaged.
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Figure 86: Hydrogel application maps for small hydrogel CAM assay

Images were taken of hydrogels directly after placement onto CAM and 24 hours
after addition to the CAM. The images acquired at the timepoints directly after placement
(0 hours) were cropped to create a 24 mm by 24 mm square around the hydrogel implant.

Figure 87: Addition of hydrogel onto CAM, left is original image, right highlights each hydrogel
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Figure 88: Hydrogel after initial addition and 24 hours later

All three eggs died before reaching 24 hours after the addition of the hydrogels, so no
conclusive data was acquired from this study. It was determined that using larger
hydrogels would allow for better imaging and data collection moving forward because of
the amount of movement from the chicken embryo.
9.1.2. CAM Assay: Large Hydrogels
After the first attempt to apply hydrogels to the CAM resulted in the deaths of all
three chicken embryos, a second incubator was used and set to the same temperature
(37°C) with water dishes in order to allow for additional eggs and to prevent the need to
stack eggs. Upon arrival, eggs were again washed, marked with “X” and “O,” and
allowed to sit at room temperature for 24 hours. Eggs were incubated for the first three
days, turning three to five times a day. On day three, all 96 eggs were cracked into 89
mm by 89 mm square weigh boats, ventilated with a 21-gauge needle, and covered with a
100 mm by 100 mm square sterile petri dish. Eggs were allowed to sit undisturbed until
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embryonic day 10 with humidity checked daily and DI water added to incubator as
needed.
Hydrogel precursor solutions of 2% Alg-MA, 2% Alg-MA and 2% Alg-Hep with
photo-initiators (0.1% v/v TEOA and 0.5% eosin Y) were prepared in PBS with and
without the addition of 1.0 µg/ml VEGF. Hydrogel precursors (0.2 mL) were added onto
a 24 well plate creating disks 12mm in diameter, which were crosslinked in visible green
(510 nm) light for 10 minutes. Three hydrogel disks were added to the eggs based on
groups, as seen in Figure 89.
2% Alg-MA +
VEGF

2% Alg-MA

2% Alg-MA &
2% Alg-Hep
+VEGF

2% Alg-MA &
2% Alg-Hep

Figure 89: Hydrogel application maps for large hydrogel CAM assay
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Images were taken of hydrogels directly after placement onto the CAM, as well as 24 and
48 hours after addition to the CAM. The images were cropped to create a 24 mm by 24
mm square around the hydrogel implant.

2% Alg-MA

2% Alg-MA

2% Alg-MA

0 Hours

24 Hours

48 Hours

Figure 90: Example of unaltered images of hydrogels in CAM assay

9.1.2.1.CAM Assay Data Analysis
The contrast levels and coloring of the images were adjusted to clearly define the
vascularization.
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2% Alg-MA
n=1

2% Alg-MA
n=2

2% Alg-MA
n=3

0 Hours

24 Hours

48 Hours

Figure 91: Example of contrasted images of hydrogels for CAM assay

2% Alg-MA
n=1

2% Alg-MA
n=2

2% Alg-MA
n=3

0 Hours

24 Hours

48 Hours

Figure 92: Example of color corrected images of hydrogels for CAM assay

The images acquired were converted into black and white images using MATLAB
software and the following example code:
Image=imread('/Users/jene/Desktop/CAM BW Take Two/h1h0b.png');
BW = imbinarize(Image);
imshowpair(Image,BW,'montage')
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Additional MATLAB code was used to calculate the number of white pixels (no
vascularization) and black pixels (vascularization):
numberOfPixels = numel(BW)
numberOfBlackPixels = sum(~BW(:))
numberOfWhitePixels = numberOfPixels-numberOfBlackPixels

Figure 93: Example of black and white image from MATLAB of hydrogels for CAM assay

From the MATLAB code, the vascularization percent increase was calculated by
comparing the number of black pixels (or vascularization) at hour 0 to the number of
black pixels at hour 24.
CAM Results
6

Vascularization Percent Increase

5

4

3

2

1

0
Alg-MA

Alg-Hep

Alg-MA +VEGF

Alg-Hep +VEGF

Control

Control VEGF

Figure 94: Results of CAM assay showing vascularization percentage increase from zero to 24 hours
(mean ± standard deviation)

Statistical analysis was preformed using a one-way ANOVA with a Bonferroni
multiple comparison post-hoc test and an a=0.05. The one-way ANOVA resulted in
failing to reject the null hypothesis and concluding that there was no significant
difference between the groups. From the graphical data, there appeared be a trend; the
conjugation of heparin, as well as the addition of VEGF, may increase the vascularization
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percentage. Additional tests and optimization of the concentrations of VEGF will need to
be performed in order to verify if conjugated heparin can increase local angiogenesis.
9.2. Preliminary Testing with 3D Printing
9.2.1. Traditional 3D Printing
Alg-MA polymer solution (2%, w/v) and photo-initiator (5% TEOA v/v and 0.5%
eosin Y v/v stock solutions) were mixed and loaded into a 3D printer. Visible green light
(510 nm) LEDs were used during the printing process. A one-layer square was printed
and crosslinked for five minutes after the completion of printing. The crosslinked
hydrogel was removed and imaged for qualitative analysis.

Figure 95: 2% Alg-MA and photo-initiators hydrogel precursor printed and crosslinked for five
minutes

9.2.2. Pluronic ® F-127 Bath
A Pluronic® suspension bath was fabricated by dissolving F-108 (PEG-b-PPG-bPEG) in cold DI water to create a 40% (w/v) solution. The solution was centrifuged at a
1690 g-force for one minute to remove air bubbles. 10 mL was added to a clear plastic
container and allowed to gel at room temperature for one hour before use. Alg-MA
polymer solution (2%, w/v) and photo-initiator (5% TEOA v/v and 0.5% eosin Y v/v
stock solutions ) were mixed in a 10 mL syringe, centrifuged to remove bubbles, and
loaded into the 3D printer. Visible green light (510 nm) LEDs were on during the printing
process. A zig zag pattern was printed. The green light was left on for 10 minutes to
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allow for complete crosslinking. The solution was placed in the refrigerator for 30
minutes to liquefy the Pluronic® support bath. The crosslinked hydrogel was removed
and imaged for qualitative analysis.
9.2.3. FRESH Bath
A gelatin and CaCl2 suspension bath was fabricated based on previously published
methods (Hinton et al., 2015). In short, gelatin was dissolved in 11 mM of CaCl2 to create
a 4.5% (w/v) solution and was allowed to gel overnight in a refrigerator. An additional 11
mM of CaCl2 (350 ml) was added to the gel and blended via a consumer grade blender.
The gelatin slurry was centrifuged for two minutes at a 3313 g-force, supernatant was
discarded, replaced with an additional 11 mM of CaCl2, vortexed and centrifuged
repeatedly until no bubbles remained in the gelatin slurry. ~10 mL of gelatin slurry was
added to a clear plastic container and allowed to gel in the refrigerator for one hour
before use. Sodium alginate, the Alg-MA polymer solution (2%, w/v) and photo-initiators
(5% TEOA v/v and 0.5% eosin Y v/v stock solutions) were mixed in a 10 mL syringe,
centrifuged to remove bubbles, and loaded into the 3D printer. A zig zag pattern was
printed. The solutions were completely crosslinked for five minutes. The solution was
placed in an incubator (37°C) for 30 minutes to liquefy the gelatin support bath. The
crosslinked hydrogel was removed and imaged for qualitative analysis.
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Figure 96: 2% Alg-MA hydrogel precursor printed in 11 mM CaCl2 FRESH bath and crosslinked
for five minutes

9.3. Additional Material Testing
9.3.1. Effects of pH on Crosslinking
Alg-MA polymer solutions (2%, w/v) and photo-initiators (5% v/v TEOA and
0.5% eosin Y v/v) were prepared in PBS at three different pH values: 5.4, 7.4, and 9.4.
Gelation kinetics of the different DOM Alg-MA precursor solutions were assessed using
an oscillatory time sweep at 1 Hz and 10% radial strain. After 30 seconds of temperature
equilibrium, a custom 9.84 cm diameter LED array (NFLS-G30X3-WHT,
SuperBrightLEDs) was used for nine minutes. Shear storage moduli (G′) were calculated
using analytical software (TA Data Analysis) and plotted with standard error bars.
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Figure 97: Storage moduli for changes in pH (mean ± standard deviation)

Altering the pH of the hydrogel precursor solution had an effect on the storage
modulus when exposed to visible green light. The higher pH value (9.4) had a lower
storage modulus. Statistical analysis was preformed using a one-way ANOVA with a
Bonferroni multiple comparison post-hoc test and an a=0.05. The one-way ANVOA
resulted in the first three timepoints (zero to two minutes) having no significant
difference between pH values. The remaining timepoints, however, had significant
differences between the groups.
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Table 9: One-way ANVOA and Bonferroni multiple comparison post-hoc test results for effect of pH
on crosslinking

Crosslink
Time
0 Mins

1 Mins

2 Mins

3 Mins

4 Mins

Comparison

Significant?

pH 5.4 to 7.4
pH 5.4 to 9.4
pH 7.4 to 9.4
pH 5.4 to 7.4
pH 5.4 to 9.4
pH 7.4 to 9.4
pH 5.4 to 7.4
pH 5.4 to 9.4
pH 7.4 to 9.4
pH 5.4 to 7.4
pH 5.4 to 9.4
pH 7.4 to 9.4
pH 5.4 to 7.4
pH 5.4 to 9.4
pH 7.4 to 9.4

No
No
No
No
No
No
No
No
No
No
No
YES
No
No
YES

Crosslink
Time
5 Mins

6 Mins

7 Mins

8 Mins

9 Mins

Comparison

Significant?

pH 5.4 to 7.4
pH 5.4 to 9.4
pH 7.4 to 9.4
pH 5.4 to 7.4
pH 5.4 to 9.4
pH 7.4 to 9.4
pH 5.4 to 7.4
pH 5.4 to 9.4
pH 7.4 to 9.4
pH 5.4 to 7.4
pH 5.4 to 9.4
pH 7.4 to 9.4
pH 5.4 to 7.4
pH 5.4 to 9.4
pH 7.4 to 9.4

No
YES
YES
No
YES
YES
No
YES
YES
YES
YES
YES
YES
YES
YES

9.3.2. Degradation
9.3.2.1. Dry to Wet Degradation
For dry to wet degradation, the hydrogel precursors were added to 1 mL syringes
and crosslinked via green light for 10 minutes. Crosslinked hydrogels were cut into 0.2
mL sections, frozen, and lyophilized. After complete drying, each sample weight was
recorded, and plugs were placed in 24 well plates with 2 mL of PBS. At each timepoint,
the appropriate plug was removed, frozen, lyophilized, and the weight was recorded.
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Figure 98: Degradation over 40 days starting from a dry plug (mean ± standard deviation)

Over the 40-days, all four hydrogel groups showed inconsistent degradation, with
the majority of values ranging between 40 and 60% loss in mass at each timepoint. From
the data it is clear that the freeze-drying process had more of an effect on the mass of the
hydrogel plug than the degradation. Due to the high polymer concentration and high
degree of crosslinking, the materials do not show significant degradation over the 40-day
testing period.
9.3.2.2.Physiological Degradation
For the physiological degradation testing, the hydrogel precursors were added to 1
mL syringes and crosslinked via green light for 10 minutes. Crosslinked hydrogels were
cut into 0.2 mL sections, weighed, and placed in 24 well plates. In each well 2 mL of
PBS was added. At each timepoint the appropriate plug was removed, frozen,
lyophilized, and the weight was recorded.
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Figure 99: Physiological degradation over 28 days (mean ± standard deviation)

During physiological degradation, similar results were found, with the majority of
values ranging between 30 and 50% loss in mass at each timepoint. Again, from the data,
no conclusions could be drawn with regard to the degradation of each hydrogel group
over a 28-day period. Because of the strength of the polymer network, longer degradation
studies as well as agitation may need to be considered in order to clearly understand the
degradation rate for each hydrogel group.
9.3.2.3. pH of Degradation Supernatant
When a material is implanted into the body it is important to ensure that the pH
changes that might occur are not extreme enough to cause site cytotoxicity. In order to
test this, the supernatant was collected during a 28-day degradation study, and the
average of three values was reported. The initial pH of the PBS that was used in the
degradation study was 7.4.
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Figure 100: pH of degrading supernatant

After the first 24 hours, in all four hydrogel groups, the supernatant surrounding
the hydrogel plug became alkaline. The 2% Alg-MA hydrogel supernatant remained
between 8.78 and 8.94, the 2% Alg-MA and 2% Alg-Hep hydrogel supernatant varied
between 8.37 and 8.44, the 2% Alg-MA and 1% Alg-b-CD hydrogel supernatant ranged
between 8.54 and 8.72, and finally the 2% Alg-MA, 2% Alg-Hep and 1% Alg-b-CD
hydrogel supernatant fluctuated between 8.38 and 8.50. Although the supernatant was
slightly alkaline, the slight increase in pH is not a major concern for implantation (Bao et
al., 2017).
9.3.3. SEM Images
The morphology of the hydrogel blends was examined using scanning electron
microscopy (SEM). The pore size of the hydrogel was highly dependent on the crosslinking density and composition of the material, both of which could easily be optimized
for desired pore sizes based on the application of the hydrogel (Q. Wang & Chen, 2016).
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Alterations to the pore sizes of these hydrogel blends can change the diffusion rates, and
therefore the swelling profiles, of the hydrogels.
9.3.3.1.Freeze Drying
Hydrogel precursor solutions for 2% Alg-MA, 2%Alg-MA and 2% Alg-Hep, 2%
Alg-MA and 1% Alg-b-CD, and %Alg-MA, 2% Alg-Hep and 1% Alg-b-CD and photoinitiators (0.1% v/v TEOA and 0.5% eosin Y) were prepared in PBS. Hydrogel precursor
solutions were loaded into 1 mL syringes and crosslinked for 10 minutes via visible green
light (510 nm). The hydrogel plugs were removed, cut into 0.2 mL sections, frozen, and
lyophilized. Dried samples were cut into thin slices and mounted onto an aluminum
specimen stub via conductive graphite tape. The samples were then sputter coated with
palladium and gold. Images were acquired with a JOEL JSM 6060 SEM machine. All
SEM images were acquired at a voltage of 15 kV and multiple magnifications.
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Figure 101: 2% Alg-MA at A) 25x magnification, B) 100x magnification, and C) 2000x magnification

A)

B)

C)

Figure 102: 2% Alg-MA and 2% Alg-Hep at A) 25x magnification, B) 100x magnification, and C)
2000x magnification
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Figure 103: 2% Alg-MA and 1% Alg-b-CD at A) 25x magnification, B) 100x magnification, and C)
2000x magnification

A)

B)

C)

Figure 104: 2% Alg-MA, 2% Alg-Hep and 1%Alg-b-CD at A) 25x magnification, B) 100x
magnification, and C) 2000x magnification
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